Identification	O
of	O
two	O
novel	O
regulatory	B-DNA
elements	I-DNA
within	O
the	O
5'-untranslated	B-DNA
region	I-DNA
of	O
the	O
human	B-DNA
A	I-DNA
gamma-globin	I-DNA
gene	I-DNA
.	O

Interaction	O
between	O
the	O
stage	B-DNA
selector	I-DNA
element	I-DNA
(	O
SSE	O
)	O
in	O
the	O
proximal	B-DNA
gamma-globin	I-DNA
promoter	I-DNA
and	O
hypersensitivity	B-DNA
site	I-DNA
2	I-DNA
in	O
the	O
locus	B-DNA
control	I-DNA
region	I-DNA
partly	O
mediates	O
the	O
competitive	O
silencing	O
of	O
the	O
beta-globin	B-DNA
promoter	I-DNA
in	O
the	O
fetal	O
developmental	O
stage	O
.	O

We	O
have	O
now	O
demonstrated	O
that	O
a	O
second	O
SSE-like	B-DNA
element	I-DNA
in	O
the	O
5'-untranslated	B-DNA
region	I-DNA
of	O
the	O
gamma-gene	B-DNA
also	O
contributes	O
to	O
this	O
competitive	O
silencing	O
of	O
the	O
beta-gene	B-DNA
.	O

Utilizing	O
transient	O
transfection	O
assays	O
in	O
the	O
fetal	B-cell_line
erythroid	I-cell_line
cell	I-cell_line
line	I-cell_line
,	O
K562	B-cell_line
,	O
we	O
have	O
shown	O
that	O
the	O
core	B-DNA
enhancer	I-DNA
of	O
hypersensitivity	B-DNA
site	I-DNA
2	I-DNA
can	O
preferentially	O
interact	O
with	O
the	O
proximal	B-DNA
gamma-promoter	I-DNA
in	O
the	O
absence	O
of	O
the	O
SSE	B-DNA
,	O
completely	O
silencing	O
a	O
linked	B-DNA
beta-promoter	I-DNA
.	O

Mutation	O
of	O
a	O
20-base	O
pair	O
sequence	O
of	O
the	O
gamma-gene	B-DNA
5'-untranslated	I-DNA
region	I-DNA
(	O
UTR	B-DNA
)	O
led	O
to	O
derepression	O
of	O
beta-promoter	B-DNA
activity	O
.	O

A	O
marked	O
activation	O
of	O
gamma-promoter	B-DNA
activity	O
was	O
also	O
observed	O
with	O
this	O
mutation	O
,	O
suggesting	O
the	O
presence	O
of	O
a	O
repressor	O
.	O

Fine	O
mutagenesis	O
dissected	O
these	O
activities	O
to	O
different	O
regions	O
of	O
the	O
5'-UTR	B-DNA
.	O

The	O
stage	O
selector	O
activity	O
was	O
localized	O
to	O
a	O
region	O
centered	O
on	O
nucleotides	B-DNA
+13	I-DNA
to	I-DNA
+15	I-DNA
.	O

Electromobility	O
shift	O
assays	O
utilizing	O
this	O
sequence	O
demonstrated	O
binding	O
of	O
a	O
fetal	B-protein
and	I-protein
erythroid-specific	I-protein
protein	I-protein
.	O

The	O
repressor	O
activity	O
of	O
the	O
5'-UTR	B-DNA
was	O
localized	O
to	O
tandem	O
GATA-like	B-DNA
sites	I-DNA
,	O
which	O
appear	O
to	O
bind	O
a	O
complex	O
of	O
two	O
proteins	O
,	O
one	O
of	O
which	O
is	O
the	O
erythroid	B-protein
transcription	I-protein
factor	I-protein
GATA-1	B-protein
.	O

These	O
results	O
indicate	O
that	O
the	O
5'-UTR	B-DNA
of	O
the	O
gamma-gene	B-DNA
contains	O
sequences	O
that	O
may	O
be	O
important	O
for	O
its	O
transcriptional	O
and	O
developmental	O
regulation	O
.	O

THz	NULL
Journat	NULL
or	NULL
Brorocicat	NULL
CHEMISTRY	NULL
©1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

270	NULL
,	NULL
No	NULL
.	NULL

21	NULL
,	NULL
Issue	NULL
of	NULL
May	NULL
26	NULL
,	NULL
pp	NULL
.	NULL

12892-12898	NULL
,	NULL
1995	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

Identification	NULL
of	NULL
Two	NULL
Novel	NULL
Regulatory	NULL
Elements	NULL
within	NULL
the	NULL
5'-Untranslated	NULL
Region	NULL
of	NULL
the	NULL
Human	NULL
4y-Globin	NULL
Gene*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
January	NULL
18	NULL
,	NULL
1995	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
March	NULL
27	NULL
,	NULL
1995	NULL
)	NULL
Persis	NULL
J.	NULL
Amroliat§	NULL
,	NULL
John	NULL
M.	NULL
Paul	NULL
Ney|	NULL
,	NULL
Arthur	NULL
W.	NULL
Nienhuist	NULL
,	NULL
and	NULL
Stephen	NULL
M.	NULL
From	NULL
the	NULL
{	NULL
Division	NULL
of	NULL
Experimental	NULL
Hematology	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
St.	NULL
Jude	NULL
Children	NULL
's	NULL
Research	NULL
Hospital	NULL
,	NULL
Memphis	NULL
,	NULL
Tennessee	NULL
38101	NULL
,	NULL
the	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
University	NULL
of	NULL
Tennessee	NULL
,	NULL
Memphis	NULL
,	NULL
Tennessee	NULL
38101	NULL
,	NULL
and	NULL
the	NULL
**Bone	NULL
Marrow	NULL
Research	NULL
Laboratory	NULL
,	NULL
Royal	NULL
Melbourne	NULL
Hospital	NULL
,	NULL
Parkville	NULL
Victoria	NULL
,	NULL
3050	NULL
,	NULL
Australia	NULL
Interaction	NULL
between	NULL
the	NULL
stage	NULL
selector	NULL
element	NULL
(	NULL
SSE	NULL
)	NULL
in	NULL
the	NULL
proximal	NULL
y-globin	NULL
promoter	NULL
and	NULL
hypersensitivity	NULL
site	NULL
2	NULL
in	NULL
the	NULL
locus	NULL
control	NULL
region	NULL
partly	NULL
mediates	NULL
the	NULL
competitive	NULL
silencing	NULL
of	NULL
the	NULL
B-globin	NULL
promoter	NULL
in	NULL
the	NULL
fetal	NULL
developmental	NULL
stage	NULL
.	NULL

We	NULL
have	NULL
now	NULL
demonstrated	NULL
that	NULL
a	NULL
second	NULL
SSE-like	NULL
element	NULL
in	NULL
the	NULL
5'-untranslated	NULL
region	NULL
of	NULL
the	NULL
y-gene	NULL
also	NULL
contributes	NULL
to	NULL
this	NULL
competitive	NULL
silencing	NULL
of	NULL
the	NULL
B-gene	NULL
.	NULL

Utilizing	NULL
transient	NULL
transfection	NULL
assays	NULL
in	NULL
the	NULL
fetal	NULL
erythroid	NULL
cell	NULL
line	NULL
,	NULL
K562	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
core	NULL
enhancer	NULL
of	NULL
hypersensitivity	NULL
site	NULL
2	NULL
can	NULL
preferentially	NULL
interact	NULL
with	NULL
the	NULL
proximal	NULL
y-promoter	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
SSE	NULL
,	NULL
completely	NULL
silencing	NULL
a	NULL
linked	NULL
B-promoter	NULL
.	NULL

Mutation	NULL
of	NULL
a	NULL
20-base	NULL
pair	NULL
sequence	NULL
of	NULL
the	NULL
y-gene	NULL
5'-untranslated	NULL
region	NULL
(	NULL
UTR	NULL
)	NULL
led	NULL
to	NULL
derepression	NULL
of	NULL
B-promoter	NULL
activity	NULL
.	NULL

A	NULL
marked	NULL
activation	NULL
of	NULL
y-promoter	NULL
activity	NULL
was	NULL
also	NULL
observed	NULL
with	NULL
this	NULL
muta-tion	NULL
,	NULL
suggesting	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
repressor	NULL
,	NULL
Fine	NULL
mutagenesis	NULL
dissected	NULL
these	NULL
activities	NULL
to	NULL
different	NULL
regions	NULL
of	NULL
the	NULL
5'-UTR	NULL
.	NULL

The	NULL
stage	NULL
selector	NULL
activity	NULL
was	NULL
localized	NULL
to	NULL
a	NULL
region	NULL
centered	NULL
on	NULL
nucleotides	NULL
+13	NULL
to	NULL
+15	NULL
.	NULL

Electromobility	NULL
shift	NULL
assays	NULL
utilizing	NULL
this	NULL
sequence	NULL
demonstrated	NULL
binding	NULL
of	NULL
a	NULL
fetal	NULL
and	NULL
erythroid-specific	NULL
protein	NULL
.	NULL

The	NULL
repressor	NULL
activity	NULL
of	NULL
the	NULL
5'-UTR	NULL
was	NULL
localized	NULL
to	NULL
tandem	NULL
GATA-like	NULL
sites	NULL
,	NULL
which	NULL
appear	NULL
to	NULL
bind	NULL
a	NULL
complex	NULL
of	NULL
two	NULL
proteins	NULL
,	NULL
one	NULL
of	NULL
which	NULL
is	NULL
the	NULL
erythroid	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
5'-UTR	NULL
of	NULL
the	NULL
y-gene	NULL
contains	NULL
sequences	NULL
that	NULL
may	NULL
be	NULL
important	NULL
for	NULL
its	NULL
transcriptional	NULL
and	NULL
developmental	NULL
regulation	NULL
.	NULL

The	NULL
normal	NULL
developmental	NULL
program	NULL
of	NULL
the	NULL
human	NULL
B-globin	NULL
locus	NULL
is	NULL
characterized	NULL
by	NULL
two	NULL
switches	NULL
in	NULL
gene	NULL
expression	NULL
:	NULL
from	NULL
embryonic	NULL
(	NULL
e	NULL
)	NULL
to	NULL
fetal	NULL
(	NULL
*y	NULL
and	NULL
*y	NULL
)	NULL
beginning	NULL
in	NULL
the	NULL
5th	NULL
week	NULL
of	NULL
gestation	NULL
and	NULL
from	NULL
fetal	NULL
to	NULL
adult	NULL
(	NULL
B	NULL
and	NULL
8	NULL
)	NULL
during	NULL
the	NULL
perinatal	NULL
period	NULL
.	NULL

This	NULL
developmental	NULL
program	NULL
is	NULL
governed	NULL
by	NULL
a	NULL
diverse	NULL
array	NULL
of	NULL
regulatory	NULL
mechanisms	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Cis-acting	NULL
elements	NULL
within	NULL
or	NULL
immediately	NULL
flanking	NULL
the	NULL
genes	NULL
themselves	NULL
can	NULL
confer	NULL
tissue	NULL
and	NULL
temporal	NULL
specificity	NULL
in	NULL
transgenic	NULL
mice	NULL
,	NULL
but	NULL
the	NULL
levels	NULL
of	NULL
expression	NULL
are	NULL
low	NULL
(	NULL
2-4	NULL
)	NULL
.	NULL

High	NULL
level	NULL
expression	NULL
is	NULL
restored	NULL
when	NULL
the	NULL
genes	NULL
are	NULL
linked	NULL
to	NULL
the	NULL
locus	NULL
control	NULL
region	NULL
(	NULL
LCR	NULL
)	NULL
,	NULL
a	NULL
*	NULL
Supported	NULL
in	NULL
part	NULL
by	NULL
Cancer	NULL
Center	NULL
Support	NULL
CORE	NULL
Grant	NULL
P30	NULL
CA	NULL
21765	NULL
,	NULL
NHLBI	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Program	NULL
Project	NULL
Grant	NULL
PO1	NULL
HL	NULL
53749-01	NULL
,	NULL
American	NULL
Lebanese	NULL
Syrian	NULL
Associated	NULL
Charities	NULL
,	NULL
the	NULL
Wellcome	NULL
Trust	NULL
,	NULL
and	NULL
NHMRC	NULL
Project	NULL
Grant	NULL
940573	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

§	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Division	NULL
of	NULL
Experimental	NULL
Hematology	NULL
,	NULL
St.	NULL
Jude	NULL
Children	NULL
's	NULL
Research	NULL
Hospital	NULL
,	NULL
332	NULL
North	NULL
Lauderdale	NULL
,	NULL
Memphis	NULL
,	NULL
TN	NULL
38101	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
901-495-2734	NULL
;	NULL
Fax	NULL
:	NULL
901-495-2176	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
LCR	NULL
,	NULL
locus	NULL
control	NULL
region	NULL
;	NULL
SSE	NULL
,	NULL
stage	NULL
regulatory	NULL
region	NULL
6-20	NULL
kilobases	NULL
5¢	NULL
of	NULL
the	NULL
e-globin	NULL
gene	NULL
that	NULL
is	NULL
characterized	NULL
by	NULL
four	NULL
erythroid-specific	NULL
DNase	NULL
1	NULL
hypersensitivity	NULL
sites	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

This	NULL
enhanced	NULL
expression	NULL
is	NULL
achieved	NULL
without	NULL
disruption	NULL
of	NULL
the	NULL
temporal	NULL
regulation	NULL
of	NULL
the	NULL
e-	NULL
and	NULL
y-genes	NULL
,	NULL
which	NULL
appear	NULL
to	NULL
be	NULL
autonomously	NULL
silenced	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
increase	NULL
in	NULL
B-gene	NULL
expression	NULL
mediated	NULL
by	NULL
the	NULL
LCR	NULL
is	NULL
accompanied	NULL
by	NULL
expression	NULL
throughout	NULL
development	NULL
.	NULL

Restoration	NULL
of	NULL
B-gene	NULL
expression	NULL
confined	NULL
to	NULL
the	NULL
adult	NULL
developmental	NULL
stage	NULL
is	NULL
only	NULL
achieved	NULL
when	NULL
the	NULL
y-gene	NULL
is	NULL
linked	NULL
in	NULL
the	NULL
normal	NULL
configuration	NULL
(	NULL
9-11	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
competition	NULL
between	NULL
the	NULL
genes	NULL
for	NULL
LCR	NULL
sequences	NULL
is	NULL
essential	NULL
for	NULL
appropriate	NULL
regulation	NULL
of	NULL
the	NULL
B-gene	NULL
.	NULL

The	NULL
concept	NULL
of	NULL
competition	NULL
between	NULL
globin	NULL
gene	NULL
promoters	NULL
for	NULL
a	NULL
shared	NULL
enhancer	NULL
as	NULL
a	NULL
mechanism	NULL
of	NULL
developmental	NULL
regulation	NULL
was	NULL
originally	NULL
proposed	NULL
for	NULL
the	NULL
chicken	NULL
globin	NULL
locus	NULL
.	NULL

In	NULL
this	NULL
system	NULL
,	NULL
silencing	NULL
of	NULL
the	NULL
embryonic	NULL
e-globin	NULL
gene	NULL
in	NULL
the	NULL
adult	NULL
stage	NULL
of	NULL
erythropoiesis	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
sequence	NULL
in	NULL
the	NULL
B-promoter	NULL
,	NULL
the	NULL
stage	NULL
selector	NULL
element	NULL
(	NULL
SSE	NULL
)	NULL
(	NULL
12	NULL
)	NULL
.	NULL

An	NULL
erythroid	NULL
and	NULL
developmentally	NULL
specific	NULL
protein	NULL
,	NULL
NF-E4	NULL
,	NULL
appears	NULL
to	NULL
facilitate	NULL
the	NULL
preferential	NULL
interaction	NULL
between	NULL
the	NULL
chick	NULL
B-promoter	NULL
and	NULL
enhancer	NULL
by	NULL
binding	NULL
to	NULL
both	NULL
regions	NULL
and	NULL
establishing	NULL
a	NULL
protein	NULL
bridge	NULL
that	NULL
brings	NULL
these	NULL
two	NULL
elements	NULL
into	NULL
apposition	NULL
(	NULL
13	NULL
)	NULL
.	NULL

In	NULL
the	NULL
human	NULL
B-globin	NULL
cluster	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
an	NULL
analogous	NULL
SSE	NULL
in	NULL
the	NULL
proximal	NULL
y-promoter	NULL
.	NULL

This	NULL
sequence	NULL
fosters	NULL
a	NULL
preferential	NULL
interaction	NULL
between	NULL
the	NULL
y-promoter	NULL
and	NULL
hypersensitivity	NULL
site	NULL
2	NULL
(	NULL
HS2	NULL
)	NULL
of	NULL
the	NULL
LCR	NULL
in	NULL
the	NULL
fetal	NULL
stage	NULL
of	NULL
erythropoiesis	NULL
,	NULL
thus	NULL
silencing	NULL
a	NULL
linked	NULL
B-promoter	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

As	NULL
with	NULL
the	NULL
chicken	NULL
SSE	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
this	NULL
element	NULL
to	NULL
confer	NULL
a	NULL
competitive	NULL
advantage	NULL
to	NULL
its	NULL
promoter	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
binding	NULL
of	NULL
a	NULL
developmentally	NULL
specific	NULL
protein	NULL
,	NULL
the	NULL
stage	NULL
selector	NULL
protein	NULL
(	NULL
SSP	NULL
)	NULL
.	NULL

The	NULL
SSP	NULL
is	NULL
a	NULL
heteromeric	NULL
complex	NULL
consisting	NULL
of	NULL
a	NULL
ubiquitous	NULL
transcription	NULL
factor	NULL
,	NULL
CP2	NULL
,	NULL
and	NULL
a	NULL
fetal/erythroid-specific	NULL
partner	NULL
protein	NULL
(	NULL
16	NULL
)	NULL
.	NULL

CP2	NULL
has	NULL
recently	NULL
been	NULL
demonstrated	NULL
to	NULL
represent	NULL
the	NULL
human	NULL
homologue	NULL
of	NULL
chicken	NULL
NF-E4	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Although	NULL
numerous	NULL
protein	NULL
footprints	NULL
have	NULL
been	NULL
demonstrated	NULL
in	NULL
HS2	NULL
,	NULL
the	NULL
site	NULL
of	NULL
interaction	NULL
with	NULL
the	NULL
SSE	NULL
is	NULL
un-known	NULL
.	NULL

HS2	NULL
contains	NULL
a	NULL
core	NULL
enhancer	NULL
element	NULL
that	NULL
binds	NULL
the	NULL
transcription	NULL
factors	NULL
NF-E2/AP-1	NULL
,	NULL
LCRF-1	NULL
,	NULL
and	NULL
NRF-2	NULL
(	NULL
17-19	NULL
)	NULL
.	NULL

Additional	NULL
cis-acting	NULL
elements	NULL
located	NULL
5	NULL
and	NULL
3	NULL
'	NULL
to	NULL
the	NULL
core	NULL
enhancer	NULL
have	NULL
also	NULL
been	NULL
defined	NULL
.	NULL

These	NULL
sites	NULL
,	NULL
known	NULL
as	NULL
co-enhancers	NULL
,	NULL
bind	NULL
the	NULL
transcriptional	NULL
regulators	NULL
Sp1	NULL
,	NULL
GATA-1	NULL
,	NULL
USF	NULL
,	NULL
and	NULL
YY1	NULL
and	NULL
contribute	NULL
to	NULL
high	NULL
level	NULL
expression	NULL
in	NULL
stable	NULL
transfectants	NULL
and	NULL
transgenic	NULL
mice	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

In	NULL
the	NULL
studies	NULL
delineated	NULL
here	NULL
,	NULL
we	NULL
sought	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
core	NULL
enhancer	NULL
of	NULL
HS2	NULL
was	NULL
sufficient	NULL
in	NULL
isolation	NULL
for	NULL
the	NULL
preferential	NULL
selector	NULL
element	NULL
;	NULL
UTR	NULL
,	NULL
untranslated	NULL
region	NULL
;	NULL
PCR	NULL
,	NULL
polymerase	NULL
chain	NULL
reaction	NULL
;	NULL
HS2	NULL
,	NULL
hypersensitivity	NULL
site	NULL
2	NULL
;	NULL
SSP	NULL
,	NULL
stage	NULL
selector	NULL
protein	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
EMSA	NULL
,	NULL
electromobility	NULL
shift	NULL
assays	NULL
.	NULL

12892	NULL
Novel	NULL
Regulatory	NULL
Elements	NULL
in	NULL
the	NULL
y-Globin	NULL
5'-UTR	NULL
interaction	NULL
between	NULL
HS2	NULL
and	NULL
the	NULL
y-promoter	NULL
.	NULL

Our	NULL
results	NULL
define	NULL
a	NULL
novel	NULL
SSE-like	NULL
element	NULL
in	NULL
the	NULL
5'-untranslated	NULL
region	NULL
(	NULL
5'-UTR	NULL
)	NULL
of	NULL
the	NULL
y-globin	NULL
gene	NULL
,	NULL
which	NULL
appears	NULL
to	NULL
preferentially	NULL
interact	NULL
with	NULL
this	NULL
enhancer	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
developmentally	NULL
specific	NULL
protein	NULL
and	NULL
thus	NULL
contribute	NULL
to	NULL
the	NULL
competitive	NULL
silencing	NULL
of	NULL
the	NULL
B-gene	NULL
in	NULL
the	NULL
fetal	NULL
stage	NULL
of	NULL
erythropoiesis	NULL
.	NULL

We	NULL
have	NULL
,	NULL
in	NULL
addition	NULL
,	NULL
identified	NULL
a	NULL
separate	NULL
negative	NULL
regulatory	NULL
element	NULL
in	NULL
this	NULL
region	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
DNA	NULL
Construction-pUC007	NULL
,	NULL
a	NULL
pUC-based	NULL
plasmid	NULL
(	NULL
17	NULL
)	NULL
,	NULL
was	NULL
used	NULL
as	NULL
the	NULL
vector	NULL
in	NULL
all	NULL
constructs	NULL
.	NULL

Constructs	NULL
containing	NULL
the	NULL
B-globin	NULL
promoter	NULL
(	NULL
-385	NULL
to	NULL
+38	NULL
)	NULL
subcloned	NULL
5	NULL
'	NULL
of	NULL
the	NULL
coding	NULL
sequence	NULL
of	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
reporter	NULL
gene	NULL
(	NULL
BCAT	NULL
)	NULL
and	NULL
the	NULL
y-promoter	NULL
(	NULL
-260	NULL
to	NULL
+35	NULL
or	NULL
-85	NULL
to	NULL
+85	NULL
)	NULL
subcloned	NULL
5	NULL
of	NULL
the	NULL
firefly	NULL
luciferase	NULL
gene	NULL
(	NULL
yLUC	NULL
or	NULL
-35yLUC	NULL
)	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
14	NULL
,	NULL
17	NULL
)	NULL
.	NULL

HS2	NULL
was	NULL
subcloned	NULL
as	NULL
a	NULL
734-bp	NULL
HindIII-Bg/lI	NULL
fragment	NULL
into	NULL
the	NULL
HindIII-BamHI	NULL
fragment	NULL
of	NULL
pUCO007	NULL
.	NULL

The	NULL
XAkol-Aatll	NULL
fragments	NULL
of	NULL
BCAT	NULL
and	NULL
yLUC	NULL
were	NULL
subcloned	NULL
3	NULL
'	NULL
of	NULL
HS2	NULL
into	NULL
a	NULL
Sall-Aatll	NULL
fragment	NULL
(	NULL
HS2BCAT	NULL
,	NULL
HS2yLUC	NULL
)	NULL
.	NULL

A	NULL
synthetic	NULL
HS2	NULL
(	NULL
HS2*	NULL
)	NULL
containing	NULL
the	NULL
tandem	NULL
NF-EZ	NULL
%	NULL
/	NULL
AP-1	NULL
sites	NULL
flanked	NULL
by	NULL
neutral	NULL
DNA	NULL
was	NULL
constructed	NULL
by	NULL
PCR	NULL
.	NULL

The	NULL
HS2	NULL
``	NULL
retains	NULL
the	NULL
spacing	NULL
between	NULL
the	NULL
core	NULL
enhancer	NULL
and	NULL
the	NULL
adjacent	NULL
promoter	NULL
but	NULL
lacks	NULL
all	NULL
the	NULL
previously	NULL
reported	NULL
co-enhancer	NULL
footprints	NULL
.	NULL

Neutral	NULL
sequences	NULL
were	NULL
designed	NULL
to	NULL
be	NULL
devoid	NULL
of	NULL
consensus	NULL
sequences	NULL
for	NULL
known	NULL
transactivators	NULL
of	NULL
the	NULL
LCR	NULL
.	NULL

Initially	NULL
,	NULL
a	NULL
163-bp	NULL
Xhol-HindIII	NULL
PCR	NULL
product	NULL
of	NULL
the	NULL
pBR322	NULL
backbone	NULL
and	NULL
a	NULL
189-bp	NULL
BgilI-Sail	NULL
PCR	NULL
product	NULL
of	NULL
the	NULL
pBR322	NULL
ampicillin	NULL
resistance	NULL
gene	NULL
were	NULL
subcloned	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
to	NULL
the	NULL
46-bp	NULL
enhancer	NULL
core	NULL
in	NULL
pUCOO07	NULL
(	NULL
22	NULL
)	NULL
.	NULL

An	NULL
additional	NULL
370-bp	NULL
BamHI-Sall	NULL
PCR	NULL
product	NULL
of	NULL
the	NULL
pBR322	NULL
tetracycline	NULL
resistance	NULL
gene	NULL
was	NULL
subcloned	NULL
3	NULL
'	NULL
to	NULL
retain	NULL
the	NULL
natural	NULL
spacing	NULL
.	NULL

The	NULL
entire	NULL
HS2Y	NULL
was	NULL
released	NULL
as	NULL
a	NULL
Sail-ActII	NULL
fragment	NULL
and	NULL
subcloned	NULL
5	NULL
'	NULL
of	NULL
either	NULL
BCAT	NULL
or	NULL
yLUC	NULL
(	NULL
HS2YBCAT	NULL
,	NULL
HS2YyLUC	NULL
)	NULL
using	NULL
the	NULL
XAol/Sall-AafII	NULL
strategy	NULL
outlined	NULL
above	NULL
.	NULL

Dual	NULL
promoter	NULL
constructs	NULL
linking	NULL
the	NULL
B-	NULL
and	NULL
-260y-promoter	NULL
(	NULL
HS28CATyLUC	NULL
,	NULL
HS2	NULL
``	NULL
8CATyLUC	NULL
)	NULL
or	NULL
the	NULL
B-	NULL
and	NULL
-35y-promoters	NULL
(	NULL
HS2BCAT-35yLUC	NULL
,	NULL
with	NULL
their	NULL
respective	NULL
reporter	NULL
genes	NULL
were	NULL
obtained	NULL
using	NULL
the	NULL
same	NULL
strategy	NULL
.	NULL

Oligonucleotides	NULL
and	NULL
Site-directed	NULL
Mutagenesis-Oligonucleotides	NULL
were	NULL
synthesized	NULL
on	NULL
an	NULL
Applied	NULL
Biosystems	NULL
synthesizer	NULL
model	NULL
380B	NULL
using	NULL
phosphoramidite	NULL
chemistry	NULL
and	NULL
purified	NULL
on	NULL
Sephadex	NULL
G-25	NULL
columns	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
Inc.	NULL
)	NULL
.	NULL

Prior	NULL
to	NULL
use	NULL
in	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
complementary	NULL
strands	NULL
were	NULL
annealed	NULL
in	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
and	NULL
10	NULL
mm	NULL
MgCl	NULL
,	NULL
by	NULL
heating	NULL
to	NULL
95	NULL
°C	NULL
for	NULL
5	NULL
min	NULL
and	NULL
slow	NULL
cooling	NULL
to	NULL
room	NULL
temperature	NULL
.	NULL

PCR	NULL
site-directed	NULL
mutagenesis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
mutants	NULL
were	NULL
made	NULL
by	NULL
PCR	NULL
in	NULL
2	NULL
halves	NULL
incorporating	NULL
a	NULL
Psfl	NULL
restriction	NULL
site	NULL
at	NULL
the	NULL
3'-end	NULL
of	NULL
one	NULL
and	NULL
the	NULL
5'-end	NULL
of	NULL
the	NULL
other	NULL
.	NULL

Products	NULL
were	NULL
cleaved	NULL
with	NULL
PstI	NULL
,	NULL
ligated	NULL
with	NULL
T4	NULL
DNA	NULL
ligase	NULL
,	NULL
and	NULL
the	NULL
full-length	NULL
mutant	NULL
amplified	NULL
by	NULL
PCR	NULL
using	NULL
the	NULL
external	NULL
primers	NULL
.	NULL

Once	NULL
subcloned	NULL
into	NULL
plasmids	NULL
,	NULL
the	NULL
sequence	NULL
was	NULL
verified	NULL
by	NULL
the	NULL
chain	NULL
termination	NULL
method	NULL
with	NULL
Sequenase	NULL
(	NULL
U.	NULL
S.	NULL
Biochemical	NULL
Corp.	NULL
)	NULL
.	NULL

Cell	NULL
Lines	NULL
and	NULL
Nuclear	NULL
Extracts-Human	NULL
erythroleukemia	NULL
(	NULL
K562	NULL
)	NULL
cells	NULL
,	NULL
murine	NULL
erythroleukemia	NULL
(	NULL
MEL	NULL
)	NULL
,	NULL
and	NULL
HeLa	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
improved	NULL
minimal	NULL
essential	NULL
medium	NULL
(	NULL
Biofluids	NULL
)	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
50	NULL
pg/ml	NULL
gentamicin	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
14	NULL
)	NULL
.	NULL

DNA	NULL
Transfection	NULL
and	NULL
Transient	NULL
Assays-Plasmid	NULL
DNA	NULL
was	NULL
prepared	NULL
over	NULL
double	NULL
cesium	NULL
chloride	NULL
gradients	NULL
.	NULL

3.5	NULL
x	NULL
10°	NULL
K562	NULL
cells	NULL
were	NULL
mixed	NULL
with	NULL
equimolar	NULL
amounts	NULL
of	NULL
the	NULL
test	NULL
plasmids	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
carrier	NULL
plasmid	NULL
(	NULL
pUC	NULL
9	NULL
)	NULL
to	NULL
a	NULL
total	NULL
of	NULL
50	NULL
ug	NULL
.	NULL

Electroporation	NULL
was	NULL
performed	NULL
with	NULL
a	NULL
Bio-Rad	NULL
gene	NULL
pulser	NULL
apparatus	NULL
at	NULL
960	NULL
microfarads	NULL
and	NULL
0.2	NULL
kV	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
20	NULL
uM	NULL
hemin	NULL
,	NULL
and	NULL
each	NULL
sample	NULL
was	NULL
split	NULL
in	NULL
two	NULL
and	NULL
harvested	NULL
after	NULL
48	NULL
h.	NULL
Cell	NULL
lysates	NULL
from	NULL
one	NULL
half	NULL
were	NULL
prepared	NULL
by	NULL
repeated	NULL
freeze-thaw	NULL
cycles	NULL
and	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
as	NULL
described	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
remaining	NULL
half	NULL
was	NULL
lysed	NULL
with	NULL
Triton	NULL
X-100	NULL
,	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
on	NULL
a	NULL
Monolight	NULL
2001	NULL
luminometer	NULL
(	NULL
Analytical	NULL
Luminescence	NULL
Laborato-ries	NULL
)	NULL
.	NULL

The	NULL
assay	NULL
was	NULL
linear	NULL
from	NULL
10*	NULL
to	NULL
10	NULL
``	NULL
light	NULL
units	NULL
;	NULL
samples	NULL
above	NULL
or	NULL
below	NULL
this	NULL
were	NULL
reassayed	NULL
with	NULL
appropriate	NULL
dilution	NULL
.	NULL

CAT	NULL
activities	NULL
were	NULL
standardized	NULL
for	NULL
lysate	NULL
protein	NULL
concentration	NULL
.	NULL

Luciferase	NULL
lysates	NULL
had	NULL
equivalent	NULL
protein	NULL
levels	NULL
.	NULL

In	NULL
our	NULL
previous	NULL
studies	NULL
,	NULL
we	NULL
had	NULL
demonstrated	NULL
that	NULL
inclusion	NULL
of	NULL
an	NULL
internal	NULL
control	NULL
reporter	NULL
plasmid	NULL
was	NULL
unsuitable	NULL
in	NULL
dual	NULL
promoter	NULL
constructs	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Standard	NULL
single	NULL
promoter	NULL
constructs	NULL
were	NULL
used	NULL
as	NULL
experimental	NULL
controls	NULL
,	NULL
and	NULL
constructs	NULL
were	NULL
only	NULL
compared	NULL
within	NULL
the	NULL
same	NULL
series	NULL
of	NULL
experiments	NULL
.	NULL

Results	NULL
shown	NULL
represent	NULL
at	NULL
least	NULL
six	NULL
different	NULL
transfections	NULL
with	NULL
two	NULL
independent	NULL
plasmid	NULL
preparations	NULL
in	NULL
induced	NULL
cells	NULL
.	NULL

Similar	NULL
trends	NULL
were	NULL
observed	NULL
in	NULL
12893	NULL
separate	NULL
transfections	NULL
of	NULL
uninduced	NULL
cells	NULL
.	NULL

Statistics	NULL
were	NULL
calculated	NULL
using	NULL
Student	NULL
's	NULL
¢	NULL
test	NULL
;	NULL
values	NULL
of	NULL
p	NULL
<	NULL
0.05	NULL
were	NULL
considered	NULL
significant	NULL
.	NULL

RNase	NULL
Protection	NULL
Assay-80	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
K562	NULL
cells	NULL
48	NULL
h	NULL
after	NULL
electroporation	NULL
using	NULL
RNAzo	NULL
!	NULL

B	NULL
(	NULL
Tel-Test	NULL
,	NULL
Friends-wood	NULL
,	NULL
TX	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Probes	NULL
were	NULL
constructed	NULL
by	NULL
subcloning	NULL
XAol-BamHI	NULL
PCR	NULL
fragments	NULL
containing	NULL
the	NULL
-35y-wild-type	NULL
or	NULL
mutant	NULL
promoters	NULL
and	NULL
the	NULL
first	NULL
243	NULL
bp	NULL
of	NULL
the	NULL
luciferase	NULL
coding	NULL
sequence	NULL
into	NULL
the	NULL
XAhol-BgilI	NULL
fragment	NULL
of	NULL
pSP73	NULL
.	NULL

Sequence	NULL
integrity	NULL
was	NULL
verified	NULL
by	NULL
dideoxy	NULL
sequencing	NULL
.	NULL

High	NULL
specific	NULL
activity	NULL
radiolabeled	NULL
transcripts	NULL
were	NULL
generated	NULL
with	NULL
SP6	NULL
RNA	NULL
polymerase	NULL
.	NULL

The	NULL
predicted	NULL
length	NULL
of	NULL
protected	NULL
fragments	NULL
from	NULL
correctly	NULL
initiated	NULL
transcripts	NULL
was	NULL
284	NULL
bp	NULL
.	NULL

RNase	NULL
protection	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
25	NULL
)	NULL
,	NULL
and	NULL
samples	NULL
were	NULL
electrophoresed	NULL
on	NULL
an	NULL
8	NULL
%	NULL
sequencing	NULL
gel	NULL
.	NULL

Gel	NULL
Mobility	NULL
Shift	NULL
Assay-Assays	NULL
were	NULL
performed	NULL
with	NULL
10°	NULL
cpm	NULL
of	NULL
probe	NULL
added	NULL
to	NULL
a	NULL
20-4l	NULL
reaction	NULL
containing	NULL
varying	NULL
amounts	NULL
of	NULL
nuclear	NULL
extract	NULL
,	NULL
500	NULL
ng	NULL
of	NULL
poly	NULL
[	NULL
d	NULL
(	NULL
GC	NULL
)	NULL
]	NULL
,	NULL
6	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
16.5	NULL
mM	NULL
KCI	NULL
,	NULL
and	NULL
100	NULL
ug	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

For	NULL
competition	NULL
assays	NULL
,	NULL
a	NULL
150-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
double-stranded	NULL
oligonucleotide	NULL
was	NULL
added	NULL
with	NULL
the	NULL
probe	NULL
.	NULL

In	NULL
antibody	NULL
studies	NULL
,	NULL
3	NULL
wl	NULL
of	NULL
pre-immune	NULL
serum	NULL
or	NULL
rat	NULL
or	NULL
rabbit	NULL
anti-mouse	NULL
GATA-1	NULL
antibody	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Merlin	NULL
Crossley	NULL
and	NULL
Stuart	NULL
Orkin	NULL
,	NULL
HHMI	NULL
,	NULL
Childrens	NULL
'	NULL
Hospital	NULL
,	NULL
Boston	NULL
)	NULL
were	NULL
preincubated	NULL
for	NULL
10	NULL
min	NULL
with	NULL
the	NULL
binding	NULL
reaction	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
the	NULL
probe	NULL
.	NULL

After	NULL
incubation	NULL
at	NULL
4°C	NULL
for	NULL
10	NULL
min	NULL
and	NULL
25°C	NULL
for	NULL
20	NULL
min	NULL
,	NULL
samples	NULL
were	NULL
electrophoresed	NULL
on	NULL
a	NULL
4	NULL
%	NULL
non-denaturing	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
0.5	NULL
x	NULL
Tris-borate-EDTA	NULL
buffer	NULL
for	NULL
90	NULL
min	NULL
at	NULL
10	NULL
V/em	NULL
.	NULL

RESULTS	NULL
The	NULL
Preferential	NULL
Interaction	NULL
between	NULL
the	NULL
Core	NULL
Enhancer	NULL
of	NULL
HS2	NULL
and	NULL
the	NULL
y-Promoter	NULL
Is	NULL
Not	NULL
Dependent	NULL
on	NULL
the	NULL
SSE-The	NULL
erythroid-specific	NULL
enhancer	NULL
in	NULL
HS2	NULL
has	NULL
been	NULL
mapped	NULL
to	NULL
a	NULL
46-bp	NULL
fragment	NULL
consisting	NULL
of	NULL
tandem	NULL
NF-E2/AP-1	NULL
binding	NULL
sites	NULL
(	NULL
17	NULL
,	NULL
22	NULL
)	NULL
.	NULL

In	NULL
our	NULL
initial	NULL
experiments	NULL
,	NULL
we	NULL
sought	NULL
to	NULL
determine	NULL
whether	NULL
this	NULL
minimal	NULL
enhancer	NULL
was	NULL
sufficient	NULL
to	NULL
preferentially	NULL
interact	NULL
with	NULL
the	NULL
y-promoter	NULL
when	NULL
in	NULL
competition	NULL
with	NULL
the	NULL
B-promoter	NULL
in	NULL
a	NULL
fetal	NULL
erythroid	NULL
environment	NULL
.	NULL

A	NULL
734-bp	NULL
HindIII-Bgill	NULL
fragment	NULL
of	NULL
HS2	NULL
and	NULL
a	NULL
synthetic	NULL
HS2	NULL
(	NULL
HS2Y	NULL
)	NULL
containing	NULL
the	NULL
46-bp	NULL
enhancer	NULL
flanked	NULL
by	NULL
neutral	NULL
DNA	NULL
to	NULL
retain	NULL
the	NULL
spacing	NULL
between	NULL
the	NULL
enhancer	NULL
and	NULL
adjacent	NULL
promoter	NULL
but	NULL
ablating	NULL
all	NULL
reported	NULL
protein	NULL
binding	NULL
sites	NULL
were	NULL
compared	NULL
.	NULL

Initially	NULL
,	NULL
each	NULL
HS2	NULL
fragment	NULL
was	NULL
linked	NULL
to	NULL
the	NULL
-378	NULL
B-promoter	NULL
with	NULL
a	NULL
CAT	NULL
reporter	NULL
gene	NULL
or	NULL
the	NULL
-260	NULL
y-promoter	NULL
with	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
and	NULL
transfected	NULL
into	NULL
K562	NULL
cells	NULL
.	NULL

With	NULL
the	NULL
y-promoter	NULL
,	NULL
reporter	NULL
gene	NULL
activity	NULL
was	NULL
4-fold	NULL
higher	NULL
in	NULL
the	NULL
context	NULL
of	NULL
HS2	NULL
than	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
presumably	NULL
reflects	NULL
the	NULL
effect	NULL
of	NULL
positive	NULL
regulatory	NULL
elements	NULL
in	NULL
HS2	NULL
outside	NULL
the	NULL
core	NULL
,	NULL
which	NULL
we	NULL
refer	NULL
to	NULL
as	NULL
co-enhancers	NULL
.	NULL

By	NULL
contrast	NULL
with	NULL
the	NULL
B-promoter	NULL
,	NULL
reporter	NULL
gene	NULL
activity	NULL
was	NULL
equivalent	NULL
with	NULL
HS2	NULL
and	NULL
HS2~	NULL
in	NULL
K562	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
constructs	NULL
1	NULL
and	NULL
4	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
the	NULL
core	NULL
enhancer	NULL
was	NULL
sufficient	NULL
for	NULL
the	NULL
competitive	NULL
advantage	NULL
of	NULL
the	NULL
y-promoter	NULL
in	NULL
the	NULL
fetal	NULL
environment	NULL
,	NULL
the	NULL
-378	NULL
B-promot-er/CAT	NULL
reporter	NULL
gene	NULL
and	NULL
-260	NULL
y-promoter/luciferase	NULL
reporter	NULL
gene	NULL
were	NULL
linked	NULL
in	NULL
competition	NULL
for	NULL
HS2	NULL
or	NULL
HS2Y	NULL
(	NULL
HS2BCATyLUC	NULL
,	NULL
HS2YBCATyLUC	NULL
)	NULL
and	NULL
transfected	NULL
into	NULL
K562	NULL
cells	NULL
.	NULL

Constructs	NULL
linking	NULL
the	NULL
HS2	NULL
fragments	NULL
to	NULL
the	NULL
B-pro-moter/CAT	NULL
reporter	NULL
hybrid	NULL
served	NULL
as	NULL
controls	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
B-promoter	NULL
activity	NULL
in	NULL
the	NULL
dual	NULL
promoter	NULL
constructs	NULL
was	NULL
diminished	NULL
10-fold	NULL
compared	NULL
with	NULL
the	NULL
controls	NULL
with	NULL
both	NULL
HS2	NULL
and	NULL
HS2Y	NULL
(	NULL
p	NULL
<	NULL
0.05	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
minimal	NULL
enhancer	NULL
was	NULL
sufficient	NULL
to	NULL
allow	NULL
preferential	NULL
interaction	NULL
of	NULL
HS2	NULL
with	NULL
the	NULL
y-promoter	NULL
(	NULL
constructs	NULL
2	NULL
and	NULL
5	NULL
)	NULL
.	NULL

The	NULL
reduction	NULL
in	NULL
y-promoter	NULL
activity	NULL
observed	NULL
in	NULL
construct	NULL
5	NULL
by	NULL
comparison	NULL
with	NULL
construct	NULL
2	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
loss	NULL
of	NULL
the	NULL
co-enhancer	NULL
effect	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
the	NULL
interaction	NULL
between	NULL
the	NULL
y-promoter	NULL
and	NULL
the	NULL
core	NULL
enhancer	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
SSE	NULL
,	NULL
we	NULL
truncated	NULL
the	NULL
y-promoter	NULL
to	NULL
-35	NULL
relative	NULL
to	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
and	NULL
examined	NULL
the	NULL
effect	NULL
in	NULL
dual	NULL
promoter	NULL
constructs	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
HS2	NULL
and	NULL
HS2	NULL
.	NULL

The	NULL
residual	NULL
y-promoter	NULL
contained	NULL
the	NULL
35	NULL
nucleotides	NULL
5	NULL
'	NULL
to	NULL
the	NULL
cap	NULL
site	NULL
and	NULL
an	NULL
additional	NULL
35	NULL
nucleotides	NULL
of	NULL
5'-UTR	NULL
.	NULL

In	NULL
the	NULL
context	NULL
of	NULL
the	NULL
wild-type	NULL
HS2	NULL
,	NULL
truncation	NULL
of	NULL
the	NULL
y-promoter	NULL
resulted	NULL
in	NULL
a	NULL
marked	NULL
decrease	NULL
in	NULL
its	NULL
activity	NULL
,	NULL
12894	NULL
Novel	NULL
Regulatory	NULL
Elements	NULL
in	NULL
the	NULL
y-Globin	NULL
5-UTR	NULL
A	NULL
FiG	NULL
.	NULL

1	NULL
.	NULL

The	NULL
minimal	NULL
y-promoter	NULL
can	NULL
(	NULL
D	NULL
ing	NULL
®	NULL
Ee	NULL
silence	NULL
a	NULL
linked	NULL
B-promoter	NULL
in	NULL
com-	NULL
s	NULL
s	NULL
is	NULL
ts	NULL
petition	NULL
for	NULL
the	NULL
HS2	NULL
core	NULL
enhancer	NULL
.	NULL

A	NULL
,	NULL
nsa	NULL
B	NULL
Car	NULL
diagrammatic	NULL
representation	NULL
of	NULL
the	NULL
con-	NULL
£	NULL
9	NULL
eal	NULL
-35r	NULL
LVC	NULL
structs	NULL
used	NULL
for	NULL
transfections	NULL
into	NULL
K562	NULL
©	NULL
sss	NULL
s	NULL
1	NULL
___	NULL
]	NULL
®	NULL
sss	NULL
cells	NULL
induced	NULL
with	NULL
hemin	NULL
.	NULL

Solid	NULL
boxes	NULL
rep-	NULL
HSaY	NULL
B	NULL
CAT	NULL
M	NULL
LUC	NULL
Hsa4	NULL
B	NULL
CA	NULL
+357	NULL
LUC	NULL
resent	NULL
either	NULL
the	NULL
734-bp	NULL
HindIII-Bg/ll	NULL
fragment	NULL
of	NULL
HS2	NULL
(	NULL
constructs	NULL
1-3	NULL
)	NULL
or	NULL
the	NULL
HS2	NULL
core	NULL
enhancer	NULL
flanked	NULL
by	NULL
neutral	NULL
DNA	NULL
to	NULL
retain	NULL
equivalent	NULL
spacing	NULL
(	NULL
constructs	NULL
4-6	NULL
)	NULL
.	NULL

The	NULL
hatched	NULL
boxes	NULL
represent	NULL
the	NULL
-385	NULL
B-promoter	NULL
linked	NULL
to	NULL
the	NULL
CAT	NULL
B	NULL
7	NULL
gene	NULL
,	NULL
and	NULL
the	NULL
open	NULL
boxes	NULL
represent	NULL
either	NULL
the	NULL
-260	NULL
(	NULL
constructs	NULL
2	NULL
and	NULL
5	NULL
)	NULL
or	NULL
the	NULL
-85	NULL
(	NULL
constructs	NULL
3	NULL
and	NULL
6	NULL
)	NULL
y-promoter	NULL
linked	NULL
to	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
.	NULL

B	NULL
,	NULL
reporter	NULL
gene	NULL
activity	NULL
of	NULL
these	NULL
constructs	NULL
.	NULL

Hatched	NULL
bars	NULL
represent	NULL
CAT	NULL
conversion	NULL
,	NULL
standardized	NULL
per	NULL
microgram	NULL
of	NULL
protein	NULL
;	NULL
open	NULL
bars	NULL
represent	NULL
luciferase	NULL
activity	NULL
(	NULL
lysates	NULL
had	NULL
equivalent	NULL
protein	NULL
concentration	NULL
}	NULL
.	NULL

Values	NULL
shown	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
S.E	NULL
.	NULL

of	NULL
at	NULL
least	NULL
six	NULL
separate	NULL
transfections	NULL
with	NULL
two	NULL
different	NULL
plasmid	NULL
preparations	NULL
.	NULL

Statistical	NULL
significance	NULL
was	NULL
assessed	NULL
using	NULL
Student	NULL
's	NULL
£	NULL
test	NULL
.	NULL

Luciferase	NULL
Activity	NULL
(	NULL
x	NULL
10	NULL
``	NULL
RLU/p1	NULL
)	NULL
presumably	NULL
due	NULL
to	NULL
loss	NULL
of	NULL
upstream	NULL
regulatory	NULL
elements	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
construct	NULL
3	NULL
)	NULL
.	NULL

Loss	NULL
of	NULL
the	NULL
SSE	NULL
in	NULL
this	NULL
setting	NULL
resulted	NULL
in	NULL
derepression	NULL
of	NULL
the	NULL
linked	NULL
B-promoter	NULL
(	NULL
p	NULL
<	NULL
0.01	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
construct	NULL
3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
level	NULL
of	NULL
B-promoter	NULL
activity	NULL
observed	NULL
in	NULL
this	NULL
construct	NULL
was	NULL
significantly	NULL
less	NULL
than	NULL
the	NULL
activity	NULL
seen	NULL
when	NULL
the	NULL
B-promoter	NULL
was	NULL
linked	NULL
to	NULL
the	NULL
same	NULL
HS2	NULL
fragment	NULL
in	NULL
isolation	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
construct	NULL
1	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
residual	NULL
competitive	NULL
sequences	NULL
may	NULL
be	NULL
present	NULL
.	NULL

This	NULL
was	NULL
confirmed	NULL
with	NULL
the	NULL
construct	NULL
linking	NULL
HS2*	NULL
``	NULL
to	NULL
the	NULL
BCAT/-35yLUC	NULL
cassette	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
construct	NULL
6	NULL
)	NULL
.	NULL

In	NULL
this	NULL
setting	NULL
,	NULL
the	NULL
-35y-promoter	NULL
totally	NULL
retained	NULL
its	NULL
competitive	NULL
advantage	NULL
,	NULL
and	NULL
the	NULL
linked	NULL
B-promoter	NULL
was	NULL
sup-pressed	NULL
.	NULL

These	NULL
findings	NULL
led	NULL
us	NULL
to	NULL
postulate	NULL
the	NULL
existence	NULL
of	NULL
alternative	NULL
stage	NULL
selector-like	NULL
elements	NULL
that	NULL
interact	NULL
specifically	NULL
with	NULL
the	NULL
HS2	NULL
core	NULL
enhancer	NULL
within	NULL
the	NULL
proximal	NULL
y-promoter	NULL
.	NULL

Localization	NULL
of	NULL
an	NULL
Alternate	NULL
Stage	NULL
Selector	NULL
Element	NULL
in	NULL
the	NULL
5'-UTR	NULL
of	NULL
the	NULL
y-Globin	NULL
Gene-To	NULL
further	NULL
localize	NULL
the	NULL
sequences	NULL
in	NULL
the	NULL
-35y-promoter	NULL
responsible	NULL
for	NULL
its	NULL
competitive	NULL
advantage	NULL
in	NULL
attracting	NULL
the	NULL
core	NULL
HS2	NULL
enhancer	NULL
,	NULL
scanning	NULL
mutagenesis	NULL
of	NULL
this	NULL
region	NULL
was	NULL
performed	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
mutants	NULL
to	NULL
compete	NULL
with	NULL
a	NULL
linked	NULL
B-promoter	NULL
for	NULL
interaction	NULL
with	NULL
HS2Y	NULL
``	NULL
was	NULL
tested	NULL
in	NULL
K562	NULL
cells	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
construct	NULL
2	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
y-TATA	NULL
box	NULL
(	NULL
-85y	NULL
``	NULL
``	NULL
)	NULL
totally	NULL
abolished	NULL
y-activity	NULL
.	NULL

Despite	NULL
this	NULL
,	NULL
no	NULL
derepression	NULL
of	NULL
the	NULL
linked	NULL
B-promoter	NULL
was	NULL
seen	NULL
,	NULL
implying	NULL
that	NULL
the	NULL
competitive	NULL
advantage	NULL
of	NULL
the	NULL
-35y-promoter	NULL
was	NULL
independent	NULL
of	NULL
its	NULL
transcriptional	NULL
activity	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
sequences	NULL
between	NULL
the	NULL
TATA	NULL
box	NULL
and	NULL
the	NULL
CAP	NULL
site	NULL
decreased	NULL
-35y-promoter	NULL
activity	NULL
slightly	NULL
but	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
repression	NULL
of	NULL
a	NULL
linked	NULL
B-promoter	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
5'-UTR	NULL
(	NULL
-35y	NULL
``	NULL
``	NULL
,	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
construct	NULL
3	NULL
)	NULL
led	NULL
to	NULL
a	NULL
3-fold	NULL
derepression	NULL
of	NULL
B-promoter	NULL
activity	NULL
(	NULL
p	NULL
<	NULL
0.05	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
area	NULL
contained	NULL
a	NULL
competitive	NULL
element	NULL
capable	NULL
of	NULL
preferentially	NULL
attracting	NULL
the	NULL
HS2	NULL
core	NULL
enhancer	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
derepression	NULL
of	NULL
the	NULL
B-promoter	NULL
,	NULL
the	NULL
20-bp	NULL
5'-UTR	NULL
mutant	NULL
also	NULL
resulted	NULL
in	NULL
a	NULL
concomitant	NULL
7-fold	NULL
increase	NULL
in	NULL
y-promoter	NULL
activity	NULL
(	NULL
p	NULL
<	NULL
0.05	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
mutation	NULL
might	NULL
also	NULL
have	NULL
disrupted	NULL
a	NULL
separate	NULL
negative	NULL
regulatory	NULL
element	NULL
.	NULL

To	NULL
further	NULL
evaluate	NULL
this	NULL
repressor	NULL
activity	NULL
,	NULL
the	NULL
wild-type	NULL
and	NULL
mutant	NULL
-35y-promoters	NULL
were	NULL
linked	NULL
to	NULL
the	NULL
HindIII-Bg	NULL
{	NULL
ll	NULL
fragment	NULL
of	NULL
HS2	NULL
as	NULL
single	NULL
promoter	NULL
constructs	NULL
and	NULL
transfected	NULL
into	NULL
K562	NULL
©	NULL
1	NULL
-S	NULL
___L__	NULL
©	NULL
-n-	NULL
T__	NULL
]	NULL
[	NULL
]	NULL
]	NULL
Luciferase	NULL
CAT	NULL
1.5	NULL
1.0	NULL
0.5	NULL
(	NULL
6r/aucd®	NULL
%	NULL
)	NULL
Anandy	NULL
0.0	NULL
cells	NULL
and	NULL
the	NULL
murine	NULL
adult	NULL
erythroid	NULL
cell	NULL
line	NULL
,	NULL
MEL	NULL
.	NULL

In	NULL
both	NULL
cell	NULL
lines	NULL
,	NULL
the	NULL
wild-type	NULL
promoter	NULL
was	NULL
less	NULL
active	NULL
than	NULL
the	NULL
mutant	NULL
,	NULL
and	NULL
a	NULL
comparable	NULL
degree	NULL
of	NULL
repression	NULL
was	NULL
observed	NULL
in	NULL
each	NULL
,	NULL
indicating	NULL
that	NULL
this	NULL
effect	NULL
was	NULL
not	NULL
developmentally	NULL
specific	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
contribution	NULL
of	NULL
the	NULL
5'-UTR	NULL
SSE-like	NULL
element	NULL
to	NULL
the	NULL
suppression	NULL
of	NULL
a	NULL
linked	NULL
B-promoter	NULL
in	NULL
the	NULL
context	NULL
of	NULL
larger	NULL
y-promoter	NULL
and	NULL
HS2	NULL
fragments	NULL
,	NULL
the	NULL
20-bp	NULL
mutation	NULL
was	NULL
made	NULL
in	NULL
the	NULL
-260y-promoter	NULL
,	NULL
and	NULL
the	NULL
ability	NULL
of	NULL
this	NULL
mutant	NULL
to	NULL
silence	NULL
a	NULL
linked	NULL
B-promoter	NULL
in	NULL
competition	NULL
for	NULL
the	NULL
734-bp	NULL
HindllII-Bglll	NULL
HS2	NULL
enhancer	NULL
was	NULL
tested	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
(	NULL
construct	NULL
2	NULL
)	NULL
,	NULL
with	NULL
the	NULL
larger	NULL
HS2	NULL
,	NULL
loss	NULL
of	NULL
the	NULL
UTR	NULL
SSE	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
derepression	NULL
of	NULL
B-promoter	NULL
activity	NULL
(	NULL
p	NULL
<	NULL
0.05	NULL
)	NULL
despite	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
intact	NULL
y-promoter	NULL
SSE	NULL
.	NULL

As	NULL
previously	NULL
shown	NULL
,	NULL
loss	NULL
of	NULL
the	NULL
y-promoter	NULL
SSE	NULL
by	NULL
truncation	NULL
to	NULL
-385	NULL
(	NULL
construct	NULL
3	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
derepression	NULL
of	NULL
linked	NULL
B-activity	NULL
(	NULL
p	NULL
<	NULL
0.05	NULL
)	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
y-promoter	NULL
SSE	NULL
,	NULL
mutation	NULL
of	NULL
5'-UTR	NULL
(	NULL
construct	NULL
4	NULL
)	NULL
led	NULL
to	NULL
a	NULL
more	NULL
marked	NULL
derepression	NULL
of	NULL
B-promoter	NULL
activity	NULL
than	NULL
that	NULL
seen	NULL
with	NULL
construct	NULL
3	NULL
(	NULL
p	NULL
<	NULL
0.05	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
two	NULL
SSE	NULL
regions	NULL
function	NULL
cooperatively	NULL
.	NULL

As	NULL
with	NULL
the	NULL
core	NULL
enhancer	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
5'-UTR	NULL
also	NULL
led	NULL
to	NULL
activation	NULL
of	NULL
-35y-promoter	NULL
activity	NULL
(	NULL
p	NULL
<	NULL
0.05	NULL
,	NULL
construct	NULL
4	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
was	NULL
less	NULL
pronounced	NULL
in	NULL
the	NULL
setting	NULL
of	NULL
the	NULL
-260y-promoter	NULL
(	NULL
construct	NULL
2	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
upstream	NULL
elements	NULL
in	NULL
the	NULL
y-promoter	NULL
can	NULL
compensate	NULL
for	NULL
the	NULL
repressor	NULL
activity	NULL
of	NULL
this	NULL
region	NULL
.	NULL

To	NULL
dissect	NULL
the	NULL
sequences	NULL
in	NULL
the	NULL
5'-UTR	NULL
responsible	NULL
for	NULL
the	NULL
SSE	NULL
and	NULL
repressor	NULL
functions	NULL
,	NULL
a	NULL
series	NULL
of	NULL
smaller	NULL
mutants	NULL
spanning	NULL
this	NULL
area	NULL
were	NULL
made	NULL
and	NULL
tested	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
compete	NULL
with	NULL
a	NULL
linked	NULL
B-promoter	NULL
for	NULL
the	NULL
HS2Y	NULL
enhancer	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
(	NULL
constructs	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
sequence	NULL
from	NULL
+13	NULL
to	NULL
+15	NULL
(	NULL
-857y	NULL
``	NULL
°	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
derepression	NULL
of	NULL
linked	NULL
B-promoter	NULL
activity	NULL
without	NULL
reduction	NULL
in	NULL
y-activity	NULL
(	NULL
p	NULL
<	NULL
0.01	NULL
)	NULL
.	NULL

No	NULL
other	NULL
mutant	NULL
demonstrated	NULL
any	NULL
B-promoter	NULL
derepression	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
suggested	NULL
that	NULL
the	NULL
nucleotides	NULL
from	NULL
+13	NULL
to	NULL
+15	NULL
may	NULL
represent	NULL
the	NULL
important	NULL
contact	NULL
bases	NULL
for	NULL
a	NULL
protein	NULL
mediating	NULL
the	NULL
SSE-like	NULL
effect	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
this	NULL
mutation	NULL
introduced	NULL
a	NULL
different	NULL
sequence	NULL
between	NULL
+13	NULL
and	NULL
+15	NULL
than	NULL
the	NULL
20-bp	NULL
mutant	NULL
,	NULL
making	NULL
it	NULL
unlikely	NULL
that	NULL
the	NULL
effect	NULL
is	NULL
specific	NULL
to	NULL
the	NULL
mutant	NULL
sequences	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
Novel	NULL
Regulatory	NULL
Elements	NULL
in	NULL
the	NULL
y-Globin	NULL
A	NULL
12895	NULL
hgaM	NULL
CAT	NULL
-357	NULL
-	NULL
LUC	NULL
hsa	NULL
cat	NULL
35	NULL
``	NULL
_	NULL
Luc	NULL
O	NULL
WWI	NULL
]	NULL
:	NULL
]	NULL
©	NULL
m	NULL
\\\\\\X	NULL
1	NULL
CTGCAG	NULL
HSaM	NULL
B	NULL
CAT	NULL
-35y	NULL
LUC	NULL
HS2M	NULL
B	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
5'-untrans-	NULL
©	NULL
@	NULL
mm	NULL
lated	NULL
region	NULL
of	NULL
the	NULL
minimal	NULL
y-promoter	NULL
activates	NULL
y-	NULL
and	NULL
derepresses	NULL
linked	NULL
B-promoter	NULL
activity	NULL
.	NULL

A	NULL
,	NULL
dia-	NULL
caP	NULL
grammatic	NULL
representation	NULL
of	NULL
constructs	NULL
.	NULL

+8	NULL
+27	NULL
In	NULL
construct	NULL
1	NULL
,	NULL
the	NULL
wild-type	NULL
minimal	NULL
``	NULL
um	NULL
y-promoter	NULL
(	NULL
-35	NULL
to	NULL
+35	NULL
)	NULL
has	NULL
been	NULL
linked	NULL
B	NULL
fAutam	NULL
to	NULL
the	NULL
-385	NULL
B-promoter	NULL
in	NULL
competition	NULL
for	NULL
7	NULL
the	NULL
HS2	NULL
core	NULL
enhancer	NULL
.	NULL

Constructs	NULL
2	NULL
and	NULL
3	NULL
3	NULL
are	NULL
identical	NULL
except	NULL
for	NULL
mutations	NULL
of	NULL
the	NULL
3	NULL
g	NULL
y-TATA	NULL
box	NULL
and	NULL
5'-untranslated	NULL
region	NULL
2	NULL
between	NULL
+8	NULL
and	NULL
+27	NULL
,	NULL
respectively	NULL
.	NULL

B	NULL
,	NULL
re-	NULL
a-	NULL
5	NULL
porter	NULL
gene	NULL
activity	NULL
of	NULL
corresponding	NULL
con-	NULL
o	NULL
structs	NULL
.	NULL

Hatched	NULL
bars	NULL
represent	NULL
CAT	NULL
con-	NULL
x	NULL
version	NULL
,	NULL
-	NULL
and	NULL
open	NULL
-	NULL
bars	NULL
-	NULL
represent	NULL
>	NULL
4	NULL
luciferase	NULL
activity	NULL
.	NULL

S	NULL
.8	NULL
3	NULL
<	NULL
P	NULL
2	NULL
C	NULL
6	NULL
30	NULL
1	NULL
3	NULL
3	NULL
0	NULL
2	NULL
B	NULL
CAT	NULL
-	NULL
LUC	NULL
car	NULL
O	NULL
psmpmpony	NULL
-_	NULL
[	NULL
___	NULL
]	NULL
2	NULL
B	NULL
CAT	NULL
LuC	NULL
©	NULL
)	NULL
mum	NULL
@	NULL
2	NULL
B	NULL
CAT	NULL
B	NULL
20	NULL
-_	NULL
C	NULL
Luciferase	NULL
3	NULL
Car	NULL
5	NULL
a	NULL
go	NULL
156	NULL
}	NULL
g	NULL
x	NULL
|-€	NULL
10	NULL
}	NULL
©	NULL
L	NULL
e	NULL
®	NULL
8	NULL
s	NULL
}	NULL
.	NULL

$	NULL
$	NULL
.	NULL

3	NULL
o	NULL
q	NULL
5'-UTR	NULL
between	NULL
+24	NULL
and	NULL
+29	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
construct	NULL
3	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
linked	NULL
B-promoter	NULL
activity	NULL
but	NULL
led	NULL
to	NULL
a	NULL
5-fold	NULL
increase	NULL
in	NULL
y-promoter	NULL
activity	NULL
(	NULL
p	NULL
<	NULL
0.05	NULL
)	NULL
.	NULL

These	NULL
nucleotides	NULL
are	NULL
centered	NULL
on	NULL
a	NULL
tandem	NULL
inverted	NULL
binding	NULL
motif	NULL
for	NULL
the	NULL
erythroid	NULL
transcription	NULL
factor	NULL
,	NULL
GATA-1	NULL
.	NULL

These	NULL
results	NULL
suggested	NULL
that	NULL
the	NULL
y-globin	NULL
5'-UTR	NULL
contains	NULL
two	NULL
distinct	NULL
regulatory	NULL
elements	NULL
,	NULL
one	NULL
analogous	NULL
to	NULL
the	NULL
SSE	NULL
and	NULL
another	NULL
that	NULL
functions	NULL
as	NULL
a	NULL
repressor	NULL
.	NULL

Functional	NULL
Mutations	NULL
in	NULL
the	NULL
Do	NULL
Not	NULL
Alter	NULL
Transcription	NULL
Initiation-Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
deletions	NULL
3	NULL
``	NULL
to	NULL
the	NULL
TATA	NULL
box	NULL
in	NULL
the	NULL
rabbit	NULL
B-globin	NULL
promoter	NULL
and	NULL
5-UTR	NULL
altered	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

To	NULL
ensure	NULL
that	NULL
the	NULL
effects	NULL
we	NULL
had	NULL
observed	NULL
with	NULL
the	NULL
UTR	NULL
mutants	NULL
were	NULL
not	NULL
attributable	NULL
to	NULL
aberrant	NULL
initiation	NULL
,	NULL
RNase	NULL
protection	NULL
analysis	NULL
was	NULL
performed	NULL
.	NULL

RNA	NULL
was	NULL
prepared	NULL
from	NULL
K562	NULL
cells	NULL
transfected	NULL
-	NULL
___	NULL
[	NULL
]	NULL
Luciferase	NULL
4.0	NULL
3.5	NULL
]	NULL
F	NULL
Car	NULL
|	NULL
g	NULL
[	NULL
V	NULL
o	NULL
|-	NULL
{	NULL
2s	NULL
§	NULL
R	NULL
7	NULL
beg	NULL
|-	NULL
120	NULL
~	NULL
,	NULL
_	NULL
129	NULL
$	NULL
L	NULL
115	NULL
g	NULL
-	NULL
4	NULL
2	NULL
11.0	NULL
£	NULL
[	NULL
7	NULL
©	NULL
|-	NULL
05	NULL
M	NULL
0.0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
-2GOY	NULL
LUC	NULL
©	NULL
\	NULL
Sofy	NULL
_	NULL
T__	NULL
2	NULL
B	NULL
Car	NULL
-357	NULL
``	NULL
``	NULL
Luc	NULL
sms	NULL
T	NULL
_	NULL
}	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
5'-untranslated	NULL
region	NULL
in	NULL
the	NULL
-260	NULL
y-promoter	NULL
also	NULL
derepresses	NULL
linked	NULL
B-promoter	NULL
activity	NULL
in	NULL
the	NULL
context	NULL
of	NULL
a	NULL
larger	NULL
HS2	NULL
fragment	NULL
.	NULL

A	NULL
,	NULL
diagrammatic	NULL
representation	NULL
of	NULL
constructs	NULL
.	NULL

In	NULL
construct	NULL
1	NULL
and	NULL
3	NULL
,	NULL
the	NULL
wild-type	NULL
-260	NULL
or	NULL
-85y-promoters	NULL
have	NULL
been	NULL
linked	NULL
to	NULL
the	NULL
-385	NULL
B-promoter	NULL
in	NULL
competition	NULL
for	NULL
the	NULL
734-bp	NULL
HindIII-Bg-III	NULL
fragment	NULL
of	NULL
HS2	NULL
.	NULL

Constructs	NULL
2	NULL
and	NULL
4	NULL
are	NULL
identical	NULL
to	NULL
these	NULL
,	NULL
respectively	NULL
,	NULL
except	NULL
for	NULL
mutation	NULL
of	NULL
the	NULL
y-5'-untranslated	NULL
region	NULL
between	NULL
+8	NULL
and	NULL
+27	NULL
.	NULL

B	NULL
,	NULL
reporter	NULL
gene	NULL
activity	NULL
of	NULL
corresponding	NULL
constructs	NULL
.	NULL

Hatched	NULL
bars	NULL
represent	NULL
CAT	NULL
conversion	NULL
,	NULL
and	NULL
open	NULL
bars	NULL
represent	NULL
luciferase	NULL
activity	NULL
.	NULL

(	NULL
br	NULL
;	NULL
auod	NULL
%	NULL
)	NULL
Auanoy	NULL
199	NULL
with	NULL
single	NULL
promoter	NULL
constructs	NULL
containing	NULL
the	NULL
-260y	NULL
,	NULL
-857	NULL
,	NULL
and	NULL
-357y	NULL
``	NULL
``	NULL
promoters	NULL
.	NULL

The	NULL
full	NULL
HS2	NULL
enhancer	NULL
was	NULL
used	NULL
to	NULL
increase	NULL
transcript	NULL
levels	NULL
.	NULL

Fig	NULL
.	NULL

5	NULL
shows	NULL
a	NULL
similar	NULL
pattern	NULL
of	NULL
one	NULL
major	NULL
and	NULL
two	NULL
minor	NULL
bands	NULL
clustered	NULL
around	NULL
the	NULL
mRNA	NULL
CAP	NULL
site	NULL
for	NULL
all	NULL
three	NULL
promoters	NULL
.	NULL

The	NULL
upper	NULL
major	NULL
band	NULL
corresponds	NULL
to	NULL
the	NULL
correctly	NULL
initiated	NULL
full-length	NULL
284-bp	NULL
mRNA	NULL
transcript	NULL
.	NULL

The	NULL
minor	NULL
smaller	NULL
bands	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
previously	NULL
reported	NULL
minor	NULL
transcripts	NULL
and	NULL
probably	NULL
represent	NULL
microhet-erogeneity	NULL
in	NULL
y-globin	NULL
transcription	NULL
initiation	NULL
sites	NULL
(	NULL
22	NULL
,	NULL
28	NULL
)	NULL
.	NULL

No	NULL
new	NULL
downstream	NULL
initiation	NULL
site	NULL
was	NULL
introduced	NULL
with	NULL
the	NULL
5'-UTR	NULL
mutation	NULL
.	NULL

Transcript	NULL
levels	NULL
with	NULL
the	NULL
repressor	NULL
mutant	NULL
were	NULL
noted	NULL
to	NULL
be	NULL
increased	NULL
in	NULL
comparison	NULL
to	NULL
the	NULL
wild-type	NULL
-35y-promoter	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
Proteins	NULL
Binding	NULL
to	NULL
the	NULL
y-Promoter	NULL
5-UTR-To	NULL
12896	NULL
A	NULL
HS2M	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

A	NULL
stage	NULL
selector-like	NULL
element	NULL
and	NULL
a	NULL
repressor	NULL
sequence	NULL
are	NULL
localized	NULL
to	NULL
different	NULL
regions	NULL
of	NULL
the	NULL
y-5'-untranslated	NULL
region	NULL
.	NULL

A	NULL
,	NULL
diagrammatic	NULL
representation	NULL
of	NULL
the	NULL
constructs	NULL
used	NULL
.	NULL

In	NULL
construct	NULL
1	NULL
,	NULL
the	NULL
-35y-promoter	NULL
has	NULL
been	NULL
linked	NULL
to	NULL
the	NULL
-385	NULL
B-promoter	NULL
in	NULL
competition	NULL
for	NULL
the	NULL
HS2	NULL
core	NULL
enhancer	NULL
.	NULL

Constructs	NULL
2	NULL
and	NULL
3	NULL
are	NULL
identical	NULL
to	NULL
construct	NULL
1	NULL
B	NULL
6	NULL
except	NULL
for	NULL
mutations	NULL
of	NULL
the	NULL
5'-untranslated	NULL
region	NULL
between	NULL
+13	NULL
and	NULL
+15	NULL
or	NULL
+24	NULL
and	NULL
+29	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
wild-type	NULL
y-5'-UTR	NULL
is	NULL
shown	NULL
under	NULL
construct	NULL
1	NULL
,	NULL
and	NULL
mutated	NULL
sequences	NULL
in	NULL
constructs	NULL
2	NULL
and	NULL
3	NULL
are	NULL
shown	NULL
in	NULL
lower	NULL
case	NULL
.	NULL

B	NULL
,	NULL
reporter	NULL
gene	NULL
activity	NULL
-	NULL
of	NULL
-	NULL
corresponding	NULL
-	NULL
constructs	NULL
.	NULL

Hatched	NULL
bars	NULL
represent	NULL
CAT	NULL
conversion	NULL
,	NULL
and	NULL
open	NULL
bars	NULL
represent	NULL
luciferase	NULL
activity	NULL
.	NULL

HS2M	NULL
Luciferase	NULL
Activity	NULL
(	NULL
x	NULL
108	NULL
RLU/u	NULL
!	NULL
)	NULL

Novel	NULL
Regulatory	NULL
Elements	NULL
in	NULL
the	NULL
y-Globin	NULL
5'-UTR	NULL
B	NULL
CAT	NULL
~35Y	NULL
-	NULL
LUC	NULL
At	NULL
``	NULL
359°	NULL
``	NULL
Luc	NULL
SI	NULL
[	NULL
___	NULL
_	NULL
HsaM	NULL
B	NULL
TGAGctgcagAATA	NULL
[	NULL
|	NULL
]	NULL
Luciferase	NULL
4	NULL
2.0	NULL
CAT	NULL
4	NULL
1.5	NULL
4	NULL
1.0	NULL
1	NULL
0.5	NULL
(	NULL
6r/auods	NULL
%	NULL
)	NULL
Auanoy	NULL
179	NULL
Probe	NULL
WT	NULL
M2	NULL
I	NULL
1	NULL
[	NULL
1	NULL
HS2	NULL
HS2	NULL
HS2	NULL
YLUC	NULL
-	NULL
-35YLUC	NULL
~-35YM2LUC	NULL
Construct	NULL
=-MW	NULL
506	NULL
summme	NULL
396	NULL
summ	NULL
344	NULL
.	NULL

298	NULL
,	NULL
does	NULL
nah	NULL
220	NULL
201	NULL
154	NULL
wor	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
y-5'-untranslated	NULL
region	NULL
does	NULL
not	NULL
alter	NULL
transcription	NULL
initiation	NULL
.	NULL

Constructs	NULL
linking	NULL
the	NULL
wild-type	NULL
-260	NULL
or	NULL
-85y-promoters	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
or	NULL
the	NULL
mutant	NULL
-35y-promoter	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
were	NULL
electroporated	NULL
into	NULL
K562	NULL
cells	NULL
and	NULL
RNA	NULL
prepared	NULL
48	NULL
h	NULL
post-transfection	NULL
.	NULL

RNase	NULL
protection	NULL
analysis	NULL
was	NULL
performed	NULL
on	NULL
80	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
or	NULL
10	NULL
ug	NULL
of	NULL
yeast	NULL
RNA	NULL
using	NULL
35	NULL
y-wild-type	NULL
(	NULL
WT	NULL
)	NULL
or	NULL
mutant	NULL
(	NULL
M2	NULL
)	NULL
RNA	NULL
probes	NULL
.	NULL

Probe	NULL
integrity	NULL
was	NULL
confirmed	NULL
by	NULL
hybridizing	NULL
to	NULL
yeast	NULL
RNA	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
RNase	NULL
(	NULL
Zanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
correctly	NULL
initiated	NULL
284-bp	NULL
protected	NULL
transcript	NULL
.	NULL

ascertain	NULL
whether	NULL
the	NULL
functional	NULL
sequences	NULL
defined	NULL
in	NULL
the	NULL
experiments	NULL
above	NULL
represented	NULL
protein	NULL
binding	NULL
sites	NULL
,	NULL
we	NULL
performed	NULL
electromobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
using	NULL
the	NULL
wild-type	NULL
y-gene	NULL
from	NULL
-5	NULL
to	NULL
+27	NULL
as	NULL
probe	NULL
(	NULL
UTR	NULL
1	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
three	NULL
retarded	NULL
bands	NULL
were	NULL
observed	NULL
with	NULL
crude	NULL
K562	NULL
nuclear	NULL
extract	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Competition	NULL
with	NULL
excess	NULL
non-radiolabeled	NULL
probe	NULL
ablated	NULL
binding	NULL
activity	NULL
,	NULL
confirming	NULL
the	NULL
specificity	NULL
of	NULL
0.0	NULL
A	NULL
Probe	NULL
CAP	NULL
r-	NULL
»	NULL
UTR1	NULL
TCCACACACTCGCTTCTG	NULL
@	NULL
GGAACGTCTGAGATTA	NULL
UTRM	NULL
:	NULL
TCCACACACTCGCTTCTGCAGCGTCTGAGAT	NULL
TA	NULL
B	NULL
Nuclear	NULL
Extract	NULL
K562	NULL
MEL	NULL
a	NULL
Probe	NULL
UTR1	NULL
UTRM	NULL
UTRi	NULL
UTRIM	NULL
UTR	NULL
HeLa	NULL
UTRM	NULL
B	NULL
ﬂ	NULL
“	NULL
.	NULL

uﬂplﬂﬂ	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

The	NULL
alternate	NULL
stage	NULL
selector	NULL
element	NULL
binds	NULL
a	NULL
protein	NULL
that	NULL
is	NULL
fetally	NULL
and	NULL
erythroid	NULL
restricted	NULL
.	NULL

A	NULL
,	NULL
sequences	NULL
of	NULL
the	NULL
upstream	NULL
y-5'-untranslated	NULL
region	NULL
probe	NULL
wild-type	NULL
(	NULL
UTR	NULL
1	NULL
)	NULL
and	NULL
mutant	NULL
(	NULL
UTR	NULL
1M	NULL
)	NULL
probes	NULL
used	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

The	NULL
mutation	NULL
at	NULL
the	NULL
site	NULL
of	NULL
the	NULL
stage	NULL
selector-like	NULL
element	NULL
is	NULL
underlined	NULL
.	NULL

B	NULL
,	NULL
EMSA	NULL
of	NULL
upstream	NULL
5'-UTR	NULL
probes	NULL
with	NULL
crude	NULL
K562	NULL
,	NULL
MEL	NULL
,	NULL
and	NULL
HeLa	NULL
nuclear	NULL
extracts	NULL
.	NULL

these	NULL
interactions	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

A	NULL
mutant	NULL
probe	NULL
(	NULL
UTR	NULL
1M	NULL
)	NULL
,	NULL
which	NULL
altered	NULL
only	NULL
the	NULL
3	NULL
bp	NULL
from	NULL
+13	NULL
to	NULL
+15	NULL
,	NULL
the	NULL
site	NULL
of	NULL
the	NULL
putative	NULL
stage	NULL
selector-like	NULL
element	NULL
,	NULL
failed	NULL
to	NULL
bind	NULL
the	NULL
uppermost	NULL
of	NULL
these	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
tissue	NULL
Novel	NULL
Regulatory	NULL
Elements	NULL
in	NULL
the	NULL
y-Globin	NULL
5'-UTR	NULL
12897	NULL
A	NULL
Probes	NULL
:	NULL
UTR2	NULL
:	NULL
CTGGAACGTCTGAIGATTATCAATAAGCTCCTAG	NULL
UTR2ZM	NULL
:	NULL
CTGGAACGTCTGAGAGGCGAAATAAGCTCCT	NULL
AG	NULL
GATA	NULL
:	NULL
GA	NULL
TAGATAGATAGATAGATAGA	NULL
TA	NULL
B	NULL
Probe	NULL
-	NULL
UTR2	NULL
>	NULL
UTRIM	NULL
cos	NULL
Cos	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

The	NULL
repressor	NULL
element	NULL
of	NULL
the	NULL
Nuclear	NULL
Extract	NULL
_	NULL
K562	NULL
MEL	NULL
-	NULL
HeLa	NULL
K562	NULL
K562	NULL
K562	NULL
(	NULL
U	NULL
)	NULL
(	NULL
GAA	NULL
)	NULL
K562	NULL
y-5'-untranslated	NULL
region	NULL
binds	NULL
two	NULL
GATA	NULL
proteins	NULL
,	NULL
one	NULL
of	NULL
which	NULL
is	NULL
GATA-1	NULL
.	NULL

A	NULL
,	NULL
Cold	NULL
Competitor	NULL
-	NULL
-	NULL
-	NULL
50	NULL
-	NULL
-	NULL
«	NULL
=	NULL
a	NULL
sequences	NULL
of	NULL
the	NULL
downstream	NULL
y-5'-UTR	NULL
(	NULL
x50	NULL
)	NULL
,	NULL
wild-type	NULL
probe	NULL
(	NULL
UTR	NULL
2	NULL
)	NULL
,	NULL
a	NULL
similar	NULL
probe	NULL
Antiseum	NULL
|	NULL
=	NULL
_	NULL
_	NULL
%	NULL
mrs	NULL
*	NULL
``	NULL
<	NULL
_	NULL
c	NULL
with	NULL
a	NULL
mutation	NULL
at	NULL
the	NULL
site	NULL
of	NULL
the	NULL
repres-	NULL
GATA-1	NULL
sor	NULL
element	NULL
(	NULL
UTR	NULL
2M	NULL
)	NULL
,	NULL
and	NULL
a	NULL
probe	NULL
consisting	NULL
of	NULL
6	NULL
GATA	NULL
repeats	NULL
used	NULL
as	NULL
a	NULL
non-radiolabeled	NULL
competitor	NULL
(	NULL
GATA	NULL
)	NULL
.	NULL

B	NULL
,	NULL
EMSA	NULL
of	NULL
wild-type	NULL
and	NULL
mutant	NULL
downstream	NULL
5'-UTR	NULL
probes	NULL
with	NULL
crude	NULL
K562	NULL
,	NULL
MEL	NULL
,	NULL
and	NULL
HeLa	NULL
nuclear	NULL
extracts	NULL
(	NULL
lanes	NULL
1-3	NULL
and	NULL
9	NULL
)	NULL
and	NULL
extracts	NULL
from	NULL
untransfected	NULL
COS	NULL
cells	NULL
(	NULL
Zane	NULL
7	NULL
)	NULL
or	NULL
COS	NULL
cells	NULL
transfected	NULL
with	NULL
a	NULL
GATA-1	NULL
expression	NULL
vector	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

Competition	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
K562	NULL
extract	NULL
preincubated	NULL
with	NULL
non-radiolabeled	NULL
GATA	NULL
probe	NULL
competitor	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
pre-immune	NULL
serum	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
or	NULL
anti-mouse	NULL
GATA-1	NULL
antibodies	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

specificity	NULL
of	NULL
this	NULL
complex	NULL
,	NULL
wild-type	NULL
and	NULL
mutant	NULL
probes	NULL
were	NULL
used	NULL
to	NULL
assay	NULL
nuclear	NULL
extracts	NULL
from	NULL
adult	NULL
erythroid	NULL
(	NULL
MEL	NULL
)	NULL
and	NULL
non-erythroid	NULL
(	NULL
HeLa	NULL
)	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lanes	NULL
3-6	NULL
)	NULL
.	NULL

Binding	NULL
activity	NULL
of	NULL
the	NULL
uppermost	NULL
complex	NULL
was	NULL
absent	NULL
in	NULL
these	NULL
extracts	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
complex	NULL
is	NULL
both	NULL
fetal	NULL
and	NULL
erythroid	NULL
spe-cific	NULL
.	NULL

Neither	NULL
a	NULL
highly	NULL
purified	NULL
preparation	NULL
of	NULL
SSP	NULL
or	NULL
recombi-nant	NULL
CP2	NULL
bound	NULL
to	NULL
the	NULL
wild-type	NULL
UTR	NULL
1	NULL
probe	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
evaluate	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
repressor	NULL
sequence	NULL
in	NULL
the	NULL
5'-UTR	NULL
,	NULL
a	NULL
probe	NULL
spanning	NULL
nucleotides	NULL
+10	NULL
to	NULL
+42	NULL
(	NULL
UTR	NULL
2	NULL
)	NULL
was	NULL
used	NULL
in	NULL
the	NULL
EMSA	NULL
with	NULL
extract	NULL
derived	NULL
from	NULL
K562	NULL
,	NULL
MEL	NULL
,	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
two	NULL
retarded	NULL
species	NULL
were	NULL
observed	NULL
with	NULL
all	NULL
extracts	NULL
.	NULL

However	NULL
,	NULL
the	NULL
broad	NULL
lower	NULL
complex	NULL
contained	NULL
a	NULL
distinct	NULL
erythroid-specific	NULL
component	NULL
in	NULL
MEL	NULL
and	NULL
K562	NULL
extract	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
tandem	NULL
inverted	NULL
GATA	NULL
motifs	NULL
with	NULL
activity	NULL
in	NULL
functional	NULL
assays	NULL
(	NULL
UTR	NULL
2M	NULL
)	NULL
abolished	NULL
binding	NULL
of	NULL
both	NULL
the	NULL
upper	NULL
ubiquitous	NULL
band	NULL
and	NULL
the	NULL
erythroid-specific	NULL
band	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
erythroid-specific	NULL
band	NULL
was	NULL
due	NULL
to	NULL
binding	NULL
of	NULL
GATA-1	NULL
,	NULL
an	NULL
excess	NULL
of	NULL
an	NULL
unlabeled	NULL
probe	NULL
consisting	NULL
of	NULL
6	NULL
repeats	NULL
of	NULL
the	NULL
GATA	NULL
motif	NULL
or	NULL
anti-mouse	NULL
GATA-1	NULL
antibodies	NULL
were	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
both	NULL
the	NULL
unlabeled	NULL
competitor	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
and	NULL
anti-mouse	NULL
GATA-1	NULL
antibody	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
significantly	NULL
reduced	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
erythroid	NULL
complex	NULL
without	NULL
altering	NULL
the	NULL
ubiquitous	NULL
band	NULL
.	NULL

Preimmune	NULL
sera	NULL
nonspecifically	NULL
diminished	NULL
both	NULL
bands	NULL
to	NULL
a	NULL
minor	NULL
degree	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
.	NULL

The	NULL
diminution	NULL
in	NULL
GATA-1	NULL
binding	NULL
observed	NULL
with	NULL
this	NULL
antisera	NULL
was	NULL
comparable	NULL
with	NULL
that	NULL
observed	NULL
by	NULL
other	NULL
investigators	NULL
.	NULL
``	NULL

To	NULL
further	NULL
validate	NULL
that	NULL
the	NULL
erythroid	NULL
complex	NULL
consisted	NULL
of	NULL
GATA-1	NULL
,	NULL
nu	NULL
2	NULL
M.	NULL
Crossley	NULL
,	NULL
personal	NULL
communication	NULL
.	NULL

clear	NULL
extract	NULL
from	NULL
COS	NULL
cells	NULL
transfected	NULL
with	NULL
a	NULL
GATA-1	NULL
expression	NULL
vector	NULL
and	NULL
extract	NULL
from	NULL
untransfected	NULL
COS	NULL
cells	NULL
was	NULL
studied	NULL
with	NULL
the	NULL
UTR	NULL
2	NULL
probe	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
,	NULL
the	NULL
GATA-1	NULL
containing	NULL
extract	NULL
produced	NULL
a	NULL
single	NULL
retarded	NULL
band	NULL
,	NULL
which	NULL
comigrated	NULL
with	NULL
the	NULL
erythroid-specific	NULL
band	NULL
seen	NULL
with	NULL
K562	NULL
extract	NULL
.	NULL

No	NULL
complex	NULL
was	NULL
observed	NULL
with	NULL
untransfected	NULL
COS	NULL
extract	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
repressor	NULL
element	NULL
of	NULL
the	NULL
5'-UTR	NULL
binds	NULL
two	NULL
proteins	NULL
,	NULL
one	NULL
of	NULL
which	NULL
is	NULL
GATA-1	NULL
.	NULL

DISCUSSION	NULL
Although	NULL
the	NULL
promoter	NULL
elements	NULL
of	NULL
the	NULL
human	NULL
globin	NULL
genes	NULL
have	NULL
been	NULL
exhaustively	NULL
studied	NULL
,	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
role	NULL
of	NULL
the	NULL
untranslated	NULL
leader	NULL
sequences	NULL
of	NULL
these	NULL
genes	NULL
.	NULL

We	NULL
now	NULL
report	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
novel	NULL
elements	NULL
in	NULL
the	NULL
5-UTR	NULL
of	NULL
the	NULL
y-gene	NULL
,	NULL
which	NULL
appear	NULL
to	NULL
have	NULL
differing	NULL
transcriptional	NULL
activi-ties	NULL
.	NULL

The	NULL
first	NULL
element	NULL
,	NULL
localized	NULL
to	NULL
a	NULL
region	NULL
centered	NULL
on	NULL
nucleotide	NULL
+14	NULL
,	NULL
functions	NULL
as	NULL
an	NULL
alternate	NULL
stage	NULL
selector	NULL
by	NULL
directing	NULL
preferential	NULL
interaction	NULL
of	NULL
the	NULL
erythroid	NULL
enhancer	NULL
of	NULL
HS2	NULL
to	NULL
the	NULL
y-gene	NULL
in	NULL
a	NULL
fetal	NULL
erythroid	NULL
environment	NULL
.	NULL

The	NULL
second	NULL
element	NULL
represses	NULL
y-promoter	NULL
activity	NULL
in	NULL
both	NULL
fetal	NULL
and	NULL
adult	NULL
stages	NULL
of	NULL
erythropoiesis	NULL
.	NULL

Both	NULL
of	NULL
these	NULL
effects	NULL
appear	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
the	NULL
competitive	NULL
advantage	NULL
of	NULL
the	NULL
y-promoter	NULL
in	NULL
the	NULL
fetal	NULL
stage	NULL
of	NULL
erythropoiesis	NULL
is	NULL
mediated	NULL
in	NULL
part	NULL
by	NULL
the	NULL
SSE	NULL
in	NULL
the	NULL
proximal	NULL
y-promoter	NULL
(	NULL
14	NULL
)	NULL
.	NULL

We	NULL
now	NULL
demonstrate	NULL
that	NULL
a	NULL
second	NULL
element	NULL
in	NULL
the	NULL
5'-UTR	NULL
(	NULL
SSE-2	NULL
)	NULL
also	NULL
contributes	NULL
to	NULL
the	NULL
preferential	NULL
interaction	NULL
of	NULL
HS2	NULL
with	NULL
the	NULL
y-promoter	NULL
.	NULL

SSE-2	NULL
is	NULL
distinct	NULL
from	NULL
the	NULL
y-promoter	NULL
SSE	NULL
in	NULL
that	NULL
its	NULL
function	NULL
is	NULL
unrelated	NULL
to	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
SSP	NULL
but	NULL
correlates	NULL
with	NULL
the	NULL
binding	NULL
of	NULL
a	NULL
second	NULL
fetal/erythroid-specific	NULL
protein	NULL
,	NULL
which	NULL
we	NULL
refer	NULL
to	NULL
as	NULL
the	NULL
UTR	NULL
stage	NULL
selector	NULL
protein	NULL
.	NULL

12898	NULL
Phylogenetic	NULL
footprint	NULL
analysis	NULL
suggests	NULL
that	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
this	NULL
protein	NULL
is	NULL
conserved	NULL
in	NULL
species	NULL
with	NULL
a	NULL
distinct	NULL
fetal	NULL
stage	NULL
of	NULL
y-gene	NULL
expression	NULL
(	NULL
30	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
is	NULL
analogous	NULL
to	NULL
the	NULL
phylogenetic	NULL
footprint	NULL
data	NULL
observed	NULL
with	NULL
the	NULL
SSE	NULL
,	NULL
suggesting	NULL
that	NULL
both	NULL
factors	NULL
may	NULL
be	NULL
integral	NULL
for	NULL
the	NULL
competitive	NULL
silencing	NULL
of	NULL
the	NULL
B-promoter	NULL
in	NULL
the	NULL
fetal	NULL
stage	NULL
of	NULL
erythropoiesis	NULL
.	NULL

Examination	NULL
of	NULL
the	NULL
binding	NULL
motif	NULL
of	NULL
the	NULL
UTR	NULL
stage	NULL
selector	NULL
protein	NULL
reveals	NULL
no	NULL
obvious	NULL
similarities	NULL
with	NULL
known	NULL
consensus	NULL
sequences	NULL
,	NULL
and	NULL
thus	NULL
the	NULL
identity	NULL
of	NULL
this	NULL
factor	NULL
is	NULL
yet	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

Our	NULL
studies	NULL
lead	NULL
us	NULL
to	NULL
propose	NULL
a	NULL
model	NULL
whereby	NULL
the	NULL
2	NULL
stage	NULL
selector	NULL
elements	NULL
function	NULL
by	NULL
stabilizing	NULL
the	NULL
interaction	NULL
between	NULL
looping	NULL
upstream	NULL
regulatory	NULL
sequences	NULL
of	NULL
the	NULL
LCR	NULL
and	NULL
the	NULL
transcriptional	NULL
machinery	NULL
of	NULL
the	NULL
y-promoter	NULL
.	NULL

SSE-2	NULL
appears	NULL
to	NULL
stabilize	NULL
the	NULL
interaction	NULL
with	NULL
the	NULL
core	NULL
enhancer	NULL
.	NULL

This	NULL
effect	NULL
may	NULL
be	NULL
mediated	NULL
by	NULL
an	NULL
interaction	NULL
between	NULL
UTR	NULL
stage	NULL
selector	NULL
protein	NULL
and	NULL
the	NULL
enhancer	NULL
protein	NULL
rather	NULL
than	NULL
an	NULL
effect	NULL
on	NULL
the	NULL
transcription	NULL
initiation	NULL
complex	NULL
,	NULL
since	NULL
capture	NULL
of	NULL
the	NULL
core	NULL
enhancer	NULL
can	NULL
occur	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
construct	NULL
2	NULL
)	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
demonstrated	NULL
that	NULL
the	NULL
SSE	NULL
in	NULL
the	NULL
proximal	NULL
y-promoter	NULL
may	NULL
function	NULL
by	NULL
recruiting	NULL
co-enhanc-ers	NULL
outside	NULL
the	NULL
HS2	NULL
core	NULL
.	NULL
``	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
large	NULL
fragments	NULL
of	NULL
HS2	NULL
,	NULL
the	NULL
2	NULL
stage	NULL
selector	NULL
elements	NULL
may	NULL
function	NULL
additively	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
loss	NULL
of	NULL
the	NULL
proximal	NULL
promoter	NULL
SSE	NULL
destabilizes	NULL
the	NULL
loop	NULL
,	NULL
and	NULL
preferential	NULL
interaction	NULL
with	NULL
the	NULL
y-promoter	NULL
is	NULL
lost	NULL
(	NULL
14	NULL
)	NULL
.	NULL

However	NULL
,	NULL
our	NULL
studies	NULL
with	NULL
the	NULL
HS2	NULL
core	NULL
enhancer	NULL
suggest	NULL
that	NULL
loss	NULL
of	NULL
the	NULL
SSE	NULL
in	NULL
this	NULL
setting	NULL
induces	NULL
less	NULL
instability	NULL
and	NULL
compensation	NULL
by	NULL
the	NULL
5	NULL
(	NULL
-UTR	NULL
SSE	NULL
occurs	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
even	NULL
when	NULL
both	NULL
stage	NULL
selector	NULL
elements	NULL
are	NULL
removed	NULL
from	NULL
the	NULL
y-promoter	NULL
,	NULL
linked	NULL
B	NULL
expression	NULL
does	NULL
not	NULL
achieve	NULL
the	NULL
levels	NULL
seen	NULL
with	NULL
the	NULL
single	NULL
B-promoter	NULL
construct	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
loss	NULL
of	NULL
the	NULL
SSEs	NULL
negates	NULL
the	NULL
competitive	NULL
advantage	NULL
of	NULL
the	NULL
y-promoter	NULL
,	NULL
and	NULL
the	NULL
two	NULL
promoters	NULL
now	NULL
compete	NULL
equally	NULL
for	NULL
HS2	NULL
.	NULL

The	NULL
co-incident	NULL
derepression	NULL
of	NULL
y-promoter	NULL
activity	NULL
with	NULL
both	NULL
the	NULL
20-bp	NULL
and	NULL
smaller	NULL
UTR	NULL
mutants	NULL
suggests	NULL
that	NULL
a	NULL
repressor	NULL
element	NULL
also	NULL
exists	NULL
in	NULL
the	NULL
region	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
effect	NULL
of	NULL
SSE-2	NULL
,	NULL
which	NULL
must	NULL
be	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
since	NULL
it	NULL
affects	NULL
a	NULL
separate	NULL
gene	NULL
transcript	NULL
,	NULL
the	NULL
repressor	NULL
effect	NULL
could	NULL
be	NULL
either	NULL
transcriptional	NULL
or	NULL
secondary	NULL
to	NULL
a	NULL
translational	NULL
block	NULL
or	NULL
altered	NULL
mRNA	NULL
stability	NULL
.	NULL

However	NULL
,	NULL
we	NULL
have	NULL
observed	NULL
that	NULL
the	NULL
fold	NULL
increase	NULL
in	NULL
y-promoter	NULL
activity	NULL
observed	NULL
with	NULL
the	NULL
mutant	NULL
was	NULL
mirrored	NULL
by	NULL
a	NULL
similar	NULL
increase	NULL
in	NULL
mRNA	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
and	NULL
that	NULL
the	NULL
magnitude	NULL
of	NULL
this	NULL
effect	NULL
was	NULL
independent	NULL
of	NULL
assay	NULL
time	NULL
.	NULL

Additional	NULL
support	NULL
for	NULL
a	NULL
transcriptional	NULL
mechanism	NULL
comes	NULL
from	NULL
the	NULL
observation	NULL
that	NULL
binding	NULL
of	NULL
the	NULL
erythroid	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
and	NULL
a	NULL
second	NULL
ubiquitous	NULL
factor	NULL
was	NULL
integral	NULL
for	NULL
repressor	NULL
activity	NULL
.	NULL

Although	NULL
we	NULL
have	NULL
no	NULL
evidence	NULL
to	NULL
differentiate	NULL
which	NULL
of	NULL
these	NULL
factors	NULL
is	NULL
mediating	NULL
this	NULL
effect	NULL
,	NULL
GATA-1	NULL
has	NULL
previously	NULL
been	NULL
demonstrated	NULL
to	NULL
transcriptionally	NULL
repress	NULL
y-gene	NULL
expression	NULL
when	NULL
binding	NULL
to	NULL
the	NULL
non-canonical	NULL
(	NULL
C/T	NULL
)	NULL
AAG	NULL
motif	NULL
at	NULL
-117	NULL
in	NULL
the	NULL
y-promoter	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
function	NULL
of	NULL
the	NULL
5-UTR	NULL
has	NULL
been	NULL
demonstrated	NULL
in	NULL
viral	NULL
and	NULL
eukaryotic	NULL
genes	NULL
as	NULL
centering	NULL
predominantly	NULL
on	NULL
translational	NULL
control	NULL
(	NULL
32-35	NULL
)	NULL
.	NULL

However	NULL
,	NULL
transcriptional	NULL
activity	NULL
of	NULL
this	NULL
region	NULL
has	NULL
also	NULL
been	NULL
demonstrated	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Sequences	NULL
downstream	NULL
of	NULL
the	NULL
HIV-1	NULL
and	NULL
HIV-2	NULL
promoters	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
influence	NULL
basal	NULL
transcription	NULL
secondary	NULL
to	NULL
binding	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
LBP-1	NULL
(	NULL
37	NULL
)	NULL
.	NULL

In	NULL
eukaryotes	NULL
,	NULL
the	NULL
Drosophila	NULL
heat	NULL
shock	NULL
gene	NULL
,	NULL
Asp22	NULL
,	NULL
is	NULL
transcriptionally	NULL
regulated	NULL
by	NULL
a	NULL
small	NULL
region	NULL
between	NULL
the	NULL
cap	NULL
site	NULL
and	NULL
nucleotide	NULL
+14	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
human	NULL
gastrin	NULL
gene	NULL
appears	NULL
to	NULL
be	NULL
transcriptionally	NULL
respon-	NULL
°	NULL
P.	NULL
J.	NULL
Amrolia	NULL
and	NULL
S.	NULL
M.	NULL
Jane	NULL
,	NULL
unpublished	NULL
observations	NULL
.	NULL

Novel	NULL
Regulatory	NULL
Elements	NULL
in	NULL
the	NULL
y-Globin	NULL
5'-UTR	NULL
sive	NULL
to	NULL
the	NULL
leader	NULL
sequence	NULL
(	NULL
89	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
5'-UTR	NULL
in	NULL
globin	NULL
gene	NULL
regulation	NULL
remains	NULL
virtually	NULL
unexplored	NULL
.	NULL

The	NULL
tran-seriptionally	NULL
active	NULL
sequences	NULL
reported	NULL
here	NULL
suggest	NULL
that	NULL
regulation	NULL
of	NULL
the	NULL
y-gene	NULL
and	NULL
the	NULL
competitive	NULL
balance	NULL
between	NULL
the	NULL
y-	NULL
and	NULL
B-genes	NULL
may	NULL
be	NULL
influenced	NULL
by	NULL
this	NULL
region	NULL
and	NULL
the	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
it	NULL
.	NULL

Although	NULL
the	NULL
relative	NULL
importance	NULL
of	NULL
these	NULL
elements	NULL
in	NULL
the	NULL
setting	NULL
of	NULL
the	NULL
entire	NULL
cluster	NULL
remains	NULL
to	NULL
be	NULL
elucidated	NULL
,	NULL
the	NULL
previous	NULL
identification	NULL
of	NULL
both	NULL
the	NULL
human	NULL
and	NULL
chicken	NULL
stage	NULL
selector	NULL
elements	NULL
in	NULL
similar	NULL
assays	NULL
provides	NULL
precedent	NULL
for	NULL
their	NULL
usefulness	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Merlin	NULL
Crossley	NULL
and	NULL
Stuart	NULL
Orkin	NULL
for	NULL
the	NULL
gift	NULL
of	NULL
anti-GATA-1	NULL
antibody	NULL
and	NULL
nuclear	NULL
extract	NULL
from	NULL
COS	NULL
cells	NULL
overexpressing	NULL
GATA-1	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Stamatoyannopoulos	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Nienhuis	NULL
,	NULL
A.	NULL
W.	NULL
(	NULL
1994	NULL
)	NULL
in	NULL
The	NULL
Molecular	NULL
Basis	NULL
of	NULL
Blood	NULL
Diseases	NULL
(	NULL
Stamatoyannopoulos	NULL
,	NULL
G.	NULL
,	NULL
Nienhuis	NULL
,	NULL
A.	NULL
W.	NULL
,	NULL
Majerus	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
and	NULL
Varmus	NULL
,	NULL
H.	NULL
,	NULL
eds	NULL
)	NULL
pp	NULL
.	NULL

107-156	NULL
,	NULL
WB	NULL
Saunders	NULL
,	NULL
Philadelphia	NULL
.	NULL

Chada	NULL
,	NULL
K.	NULL
,	NULL
Magram	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Costantini	NULL
,	NULL
F.	NULL
(	NULL
1986	NULL
)	NULL
Nature	NULL
$	NULL
19	NULL
,	NULL
685~689	NULL
.	NULL

Kollias	NULL
,	NULL
G.	NULL
,	NULL
Wrighton	NULL
,	NULL
N.	NULL
,	NULL
Hurst	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Grosveld	NULL
,	NULL
F.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
46	NULL
,	NULL
89-94	NULL
.	NULL

Townes	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Lingrel	NULL
,	NULL
J	NULL
.	NULL

B	NULL
,	NULL
Chen	NULL
,	NULL
H.	NULL
Y.	NULL
,	NULL
Brinster	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
and	NULL
Palmiter	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1985	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

4	NULL
,	NULL
1715-1723	NULL
5	NULL
.	NULL

Grosveld	NULL
,	NULL
F.	NULL
,	NULL
van	NULL
Assendelft	NULL
,	NULL
G.	NULL
B.	NULL
,	NULL
Greaves	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
and	NULL
Kollias	NULL
,	NULL
G.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
51	NULL
,	NULL
975-985	NULL
6	NULL
.	NULL

Talbot	NULL
,	NULL
D.	NULL
,	NULL
Collis	NULL
,	NULL
P.	NULL
,	NULL
Antoniou	NULL
,	NULL
M.	NULL
,	NULL
Vidal	NULL
,	NULL
M.	NULL
,	NULL
Grosveld	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Greaves	NULL
,	NULL
D.	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
388	NULL
,	NULL
352-355	NULL
.	NULL

Dillon	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Grasveld	NULL
,	NULL
F.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
350	NULL
,	NULL
252-254	NULL
.	NULL

Raich	NULL
,	NULL
N.	NULL
,	NULL
Enver	NULL
,	NULL
T.	NULL
,	NULL
Nakamoto	NULL
,	NULL
B.	NULL
,	NULL
Josephson	NULL
,	NULL
B.	NULL
,	NULL
Papayannopoulou	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Stamatoyannopoulos	NULL
,	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
250	NULL
,	NULL
1147-1149	NULL
9	NULL
.	NULL

Enver	NULL
,	NULL
T.	NULL
,	NULL
Raich	NULL
,	NULL
N.	NULL
,	NULL
Ebens	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Papayannopoulou	NULL
,	NULL
T.	NULL
,	NULL
Costantini	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Stamatoyannopoulos	NULL
,	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
344	NULL
,	NULL
309-313	NULL
10	NULL
.	NULL

Behringer	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
Ryan	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Palmiter	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
Brinster	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
and	NULL
Townes	NULL
,	NULL
T.	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
380-389	NULL
11	NULL
.	NULL

Hanscombe	NULL
,	NULL
O.	NULL
,	NULL
Whyatt	NULL
,	NULL
D.	NULL
,	NULL
Fraser	NULL
,	NULL
P.	NULL
,	NULL
Yannoutsos	NULL
,	NULL
N.	NULL
,	NULL
Greaves	NULL
,	NULL
D.	NULL
,	NULL
Dillon	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Grosveld	NULL
,	NULL
F.	NULL
(	NULL
1991	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
1387-1394	NULL
12	NULL
.	NULL

Choi	NULL
,	NULL
O.	NULL
R.	NULL
B.	NULL
,	NULL
and	NULL
Engel	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
55	NULL
,	NULL
17-26	NULL
13	NULL
.	NULL

Gallarda	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Foley	NULL
,	NULL
K.	NULL
P.	NULL
,	NULL
Yang	NULL
,	NULL
Z.	NULL
,	NULL
and	NULL
Engel	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

8	NULL
,	NULL
1845-1859	NULL
14	NULL
.	NULL

Jane	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Ney	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Vanin	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
Gumucio	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
and	NULL
Nienhuis	NULL
,	NULL
A.	NULL
W.	NULL
(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

11	NULL
,	NULL
2961-2969	NULL
15	NULL
.	NULL

Jane	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Gumucio	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Ney	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Cunningham	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Nienhuis	NULL
,	NULL
A.	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
3272-3281	NULL
16	NULL
.	NULL

Jane	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Nienhuis	NULL
,	NULL
A.	NULL
W.	NULL
,	NULL
and	NULL
Cunningham	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

14	NULL
,	NULL
97-105	NULL
17	NULL
.	NULL

Ney	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Sorrentino	NULL
,	NULL
B.	NULL
P.	NULL
,	NULL
McDonagh	NULL
,	NULL
K.	NULL
T.	NULL
,	NULL
and	NULL
Nienhuis	NULL
,	NULL
A.	NULL
W.	NULL
(	NULL
1990	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
993-1006	NULL
18	NULL
.	NULL

Chan	NULL
,	NULL
J.	NULL
Y.	NULL
,	NULL
Han	NULL
,	NULL
X.	NULL
L.	NULL
,	NULL
and	NULL
Kan	NULL
,	NULL
Y.	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
11371-11375	NULL
19	NULL
.	NULL

Moi	NULL
,	NULL
P.	NULL
,	NULL
Chan	NULL
,	NULL
K.	NULL
,	NULL
Asunis	NULL
,	NULL
I.	NULL
,	NULL
Cao	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Kan	NULL
,	NULL
Y.	NULL
W.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Nati	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
9926-9930	NULL
20	NULL
.	NULL

Talbot	NULL
,	NULL
D.	NULL
,	NULL
Philipsen	NULL
,	NULL
S.	NULL
,	NULL
Fraser	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Grosveld	NULL
,	NULL
F.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
2169-2177	NULL
21	NULL
.	NULL

Ellis	NULL
,	NULL
J.	NULL
,	NULL
Talbot	NULL
,	NULL
D.	NULL
,	NULL
Dillon	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Grosveld	NULL
,	NULL
F.	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
127-134	NULL
22	NULL
.	NULL

Sorrentino	NULL
,	NULL
B.	NULL
,	NULL
Ney	NULL
,	NULL
P.	NULL
,	NULL
Bodine	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Nienhuis	NULL
,	NULL
A.	NULL
W.	NULL
(	NULL
1990	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18	NULL
,	NULL
2721-2731	NULL
23	NULL
.	NULL

Gustin	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
and	NULL
Burk	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1998	NULL
)	NULL
BioTechniques	NULL
14	NULL
,	NULL
22-23	NULL
24	NULL
.	NULL

Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Moffat	NULL
,	NULL
L.	NULL
F.	NULL
,	NULL
and	NULL
Howard	NULL
,	NULL
B.	NULL
H.	NULL
(	NULL
1982	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2	NULL
,	NULL
1044-1051	NULL
25	NULL
.	NULL

Calzone	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
Britten	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Davidson	NULL
,	NULL
E.	NULL
H.	NULL
(	NULL
1987	NULL
)	NULL
Methods	NULL
Enzymol	NULL
.	NULL

152	NULL
,	NULL
611-632	NULL
26	NULL
.	NULL

Fried	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Crothers	NULL
,	NULL
D.	NULL
M.	NULL
(	NULL
1981	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

9	NULL
,	NULL
6505-6525	NULL
27	NULL
.	NULL

Strauss	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Varshavsky	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Cell	NULL
37	NULL
,	NULL
889-901	NULL
28	NULL
.	NULL

Grosveld	NULL
,	NULL
G.	NULL
C.	NULL
,	NULL
Shewmaker	NULL
,	NULL
C.	NULL
K.	NULL
,	NULL
Jat	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Flavell	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1981	NULL
)	NULL
Cell	NULL
25	NULL
,	NULL
215-226	NULL
29	NULL
.	NULL

Grosveld	NULL
,	NULL
G.	NULL
C.	NULL
,	NULL
De	NULL
Boer	NULL
,	NULL
E.	NULL
,	NULL
Shewmaker	NULL
,	NULL
C.	NULL
K.	NULL
,	NULL
and	NULL
Flavell	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
Nature	NULL
295	NULL
,	NULL
120-126	NULL
30	NULL
.	NULL

Gumucio	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Heilstedt-Williamson	NULL
,	NULL
H.	NULL
,	NULL
Gray	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Tarle	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Shelton	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Tagle	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Slightom	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Goodman	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Collins	NULL
,	NULL
F.	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
4919-4929	NULL
31	NULL
.	NULL

Berry	NULL
,	NULL
M.	NULL
,	NULL
Grosveld	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Dillon	NULL
,	NULL
N.	NULL
(	NULL
1992	NULL
)	NULL
Nature	NULL
358	NULL
,	NULL
499-502	NULL
32	NULL
.	NULL

Rao	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Pech	NULL
,	NULL
M.	NULL
,	NULL
Robbins	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
and	NULL
Aaronson	NULL
,	NULL
S.	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

im	NULL
G	NULL
ND	NULL
go	NULL
~a	NULL
8	NULL
,	NULL
284-292	NULL
33	NULL
.	NULL

Prats	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Vagner	NULL
,	NULL
S.	NULL
,	NULL
Prats	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Amalric	NULL
,	NULL
F.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
4796-4805	NULL
34	NULL
.	NULL

Dix	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Lin	NULL
,	NULL
P.	NULL
N.	NULL
,	NULL
Kimata	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Theil	NULL
,	NULL
E.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
Biochemistry	NULL
31	NULL
,	NULL
2818-2822	NULL
35	NULL
.	NULL

Geballe	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
Spaete	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
and	NULL
Mocarski	NULL
,	NULL
E.	NULL
S.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
46	NULL
,	NULL
865-872	NULL
36	NULL
.	NULL

Mansour	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Grodzicker	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1986	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

6	NULL
,	NULL
2684-2694	NULL
37	NULL
.	NULL

Jones	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Luciw	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Duchange	NULL
,	NULL
N.	NULL
(	NULL
1988	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

2	NULL
,	NULL
1101-1114	NULL
38	NULL
.	NULL

Hultmark	NULL
,	NULL
D.	NULL
,	NULL
Klemenz	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Gehring	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Cell	NULL
44	NULL
,	NULL
429-438	NULL
39	NULL
.	NULL

Theill	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
Wiborg	NULL
,	NULL
O.	NULL
,	NULL
and	NULL
Vuust	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
,	NULL
4329-4336	NULL

